{"content":"<li class=\"n-box-item date-title\" data-end=\"1575435599\" data-start=\"1575349200\" data-txt=\"Monday, December 23, 2019\">Tuesday, December  3, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3523522\" data-ts=\"1575413801\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JNJ\" target=\"_blank\">JNJ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523522-jnj-says-no-asbestos-found-in-baby-powder\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JNJ says no asbestos found in baby powder</a></h4><ul><li>Tests conducted by two third-party labs show asbestos was not present in the single bottle that the FDA's contracted lab tested, nor was it present in retained samples of the finished lot from which the bottle was produced.</li><li>Further, JNJ's (NYSE:<a href='https://seekingalpha.com/symbol/JNJ' title='Johnson & Johnson'>JNJ</a>) investigation showed the testing protocol at said lab deviated from standard practice.</li><li>Shares are <font color=\"green\">up 0.6%</font> after hours.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17717381-company-investigation-confirms-no-asbestos-in-johnsons-baby-powder\" target=\"_blank\">Press Release</a></li><li><strong>Update</strong>: Reuters reports that the FDA stands by the results of its study that showed traces of asbestos in the product.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523522\" data-linked=\"JNJ says no asbestos found in baby powder\" data-tweet=\"$JNJ - JNJ says no asbestos found in baby powder https://seekingalpha.com/news/3523522-jnj-says-no-asbestos-found-in-baby-powder?source=tweet\" data-url=\"https://seekingalpha.com/news/3523522-jnj-says-no-asbestos-found-in-baby-powder\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>43&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523518\" data-ts=\"1575412803\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MA\" target=\"_blank\">MA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523518-mastercard-oks-new-8b-stock-buyback-raises-dividend\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mastercard OKs new $8B stock buyback, raises dividend</a></h4><ul><li>Mastercard (NYSE:<a href='https://seekingalpha.com/symbol/MA' title='Mastercard Incorporated'>MA</a>) <font color=\"green\">+1.5%</font> after-hours after <a href=\"https://seekingalpha.com/news/3523502-mastercard-declares-0_40-dividend\" target=\"_blank\">increasing its quarterly dividend</a> to $0.40/share from $0.33/share and authorizing the repurchase of as much as $8B of Class A common stock.</li><li>MA says the new buyback plan will take effect at the conclusion of the current $6.5B repurchase program, which has ~$300M remaining under its authorization.</li><li>MA has a $294.7B market cap, 1B shares outstanding and a public float of 884.5M shares.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523518\" data-linked=\"Mastercard OKs new $8B stock buyback, raises dividend\" data-tweet=\"$MA - Mastercard OKs new $8B stock buyback, raises dividend https://seekingalpha.com/news/3523518-mastercard-oks-new-8b-stock-buyback-raises-dividend?source=tweet\" data-url=\"https://seekingalpha.com/news/3523518-mastercard-oks-new-8b-stock-buyback-raises-dividend\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>49&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523517\" data-ts=\"1575412351\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523517-healthequity-leads-after-hour-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">HealthEquity leads after hour gainers</a></h4><ul><li><strong>Gainers: </strong><a href='https://seekingalpha.com/symbol/HQY' title='HealthEquity, Inc.'>HQY</a> <font color=\"green\">+11.9%</font>. <a href='https://seekingalpha.com/symbol/RAPT' title='RAPT Therapeutics, Inc.'>RAPT</a> <font color=\"green\">+8.2%</font>. <a href='https://seekingalpha.com/symbol/CIH' title='China Index Holdings Limited'>CIH</a> <font color=\"green\">+8.2%</font>. <a href='https://seekingalpha.com/symbol/SIGA' title='SIGA Technologies, Inc.'>SIGA</a> <font color=\"green\">+5.0%</font>. <a href='https://seekingalpha.com/symbol/NPO' title='EnPro Industries, Inc.'>NPO</a> <font color=\"green\">+4.8%</font>.</li><li><strong>Losers: </strong><a href='https://seekingalpha.com/symbol/RVNC' title='Revance Therapeutics, Inc.'>RVNC</a> <font color=\"red\">-10.4%</font>. <a href='https://seekingalpha.com/symbol/QMCO' title='Quantum Corporation'>OTCPK:QMCO</a> <font color=\"red\">-9.5%. </font><a href='https://seekingalpha.com/symbol/IMMU' title='Immunomedics, Inc.'>IMMU</a> <font color=\"red\">-7.9%</font>. <a href='https://seekingalpha.com/symbol/ADMS' title='Adamas Pharmaceuticals, Inc.'>ADMS</a> <font color=\"red\">-6.5%</font>. <a href='https://seekingalpha.com/symbol/ZS' title='Zscaler, Inc.'>ZS</a> <font color=\"red\">-5.5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523517\" data-linked=\"HealthEquity leads after hour gainers\" data-tweet=\"$HQY $RAPT $CIH - HealthEquity leads after hour gainers https://seekingalpha.com/news/3523517-healthequity-leads-after-hour-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3523517-healthequity-leads-after-hour-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:32 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523514\" data-ts=\"1575411390\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MCHP\" target=\"_blank\">MCHP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523514-mchpplus-2_4-after-q3-outlook-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MCHP +2.4% after Q3 outlook update</a></h4><ul><li>Microchip (NASDAQ:<a href='https://seekingalpha.com/symbol/MCHP' title='Microchip Technology Incorporated'>MCHP</a>) <a href=\"https://seekingalpha.com/pr/17717256-microchip-technology-updates-financial-guidance-for-third-quarter-fiscal-2020\" target=\"_blank\">narrows</a> its Q3 revenue outlook from $1.204B-1.311B to $1.244B-1.298B.</li><li>The company sees EPS of $1.19-1.30 versus the prior $1.12-1.32.</li><li>MCHP says the strong bookings trend reported for October continued in November. QTD bookings for December have also been strong.</li><li>Microchip shares are <font color=\"green\">up 2.4%</font> after hours to $94.05.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523514\" data-linked=\"MCHP +2.4% after Q3 outlook update\" data-tweet=\"$MCHP - MCHP +2.4% after Q3 outlook update https://seekingalpha.com/news/3523514-mchpplus-2_4-after-q3-outlook-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3523514-mchpplus-2_4-after-q3-outlook-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:16 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523506\" data-ts=\"1575410559\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WDAY\" target=\"_blank\">WDAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523506-workday-slides-during-call-guides-upside-q4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Workday slides during call, guides upside Q4</a></h4><ul><li>During the earnings call, Workday (NASDAQ:<a href='https://seekingalpha.com/symbol/WDAY' title='Workday, Inc.'>WDAY</a>) guides Q4 subscription revenue of $828M-830M versus the $826.8M consensus.</li><li>The company raises its FY20 subscription revenue outlook to $3.085B-3.087B from $3.06B-3.07B.</li><li>For FY21, WDAY sees subscription revenue growth of 21%, below the 23.6% estimate.</li><li>WDAY shares are <font color=\"red\">down 2.5%</font>, erasing the gains that followed the <a href=\"https://seekingalpha.com/news/3523473-workdayplus-1-after-upside-q3-report\" target=\"_blank\">upside Q3 report</a>.</li><li>Post updated with more information.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523506\" data-linked=\"Workday slides during call, guides upside Q4\" data-tweet=\"$WDAY - Workday slides during call, guides upside Q4 https://seekingalpha.com/news/3523506-workday-slides-during-call-guides-upside-q4?source=tweet\" data-url=\"https://seekingalpha.com/news/3523506-workday-slides-during-call-guides-upside-q4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523504\" data-ts=\"1575409855\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GPRO\" target=\"_blank\">GPRO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523504-goproplus-2-on-strong-black-friday-sales\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GoPro +2% on strong Black Friday sales</a></h4><ul><li>GoPro (NASDAQ:<a href='https://seekingalpha.com/symbol/GPRO' title='GoPro, Inc.'>GPRO</a>) <a href=\"https://seekingalpha.com/pr/17717279-gopro-hero8-black-sets-record-for-best-selling-gopro-ever-over-black-friday-cyber-monday\" target=\"_blank\">reports</a> a Y/Y sell-through growth of 30% based on available data from its larger U.S. retail partners and 20% based on European retail partners during the week of Black Friday.</li><li>For the entire Black Friday and Cyber Monday period, GoPro says total camera unit sales grew more than 120% Y/Y with the HERO8 Black accounting for 90% of total sales.</li><li>GPRO shares are <font color=\"green\">up 2.3%</font> after hours to $3.95.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523504\" data-linked=\"GoPro +2% on strong Black Friday sales\" data-tweet=\"$GPRO - GoPro +2% on strong Black Friday sales https://seekingalpha.com/news/3523504-goproplus-2-on-strong-black-friday-sales?source=tweet\" data-url=\"https://seekingalpha.com/news/3523504-goproplus-2-on-strong-black-friday-sales\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523500\" data-ts=\"1575409267\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZS\" target=\"_blank\">ZS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523500-zscalerminus-5_6-on-weak-q2-view\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zscaler -5.6% on weak Q2 view</a></h4><ul><li>Zscaler (NASDAQ:<a href='https://seekingalpha.com/symbol/ZS' title='Zscaler, Inc.'>ZS</a>) <font color=\"red\">-5.6% </font><a href=\"https://seekingalpha.com/news/3523492-zscaler-eps-beats-0_02-beats-on-revenue\" target=\"_blank\">reports</a> an upside Q1 report but has a more muted view for Q2 with inline revenue of $97-100M and downside EPS of about $0.03 compared to the $0.04 consensus.</li><li>For FY20, ZS sees inline EPS of $0.13-0.15 and upside revenue of $405-413M.</li><li>Q1 calculated billings were up 48% Y/Y to $94M.</li><li>Deferred revenue was up 49% to $246M.</li><li>Cash from operations totaled $21.4M (last year: $11M) with FCF of $9.4M.</li><li>Cash and equivalents totaled $378M at the end of the quarter.</li><li>Earnings call started at 4:30 PM with a webcast <a href=\"https://ir.zscaler.com/\" target=\"_blank\">here</a>.</li><li><a href=\"https://seekingalpha.com/pr/17717229-zscaler-reports-first-quarter-fiscal-2020-financial-results\" target=\"_blank\">Press release</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523500\" data-linked=\"Zscaler -5.6% on weak Q2 view\" data-tweet=\"$ZS - Zscaler -5.6% on weak Q2 view https://seekingalpha.com/news/3523500-zscalerminus-5_6-on-weak-q2-view?source=tweet\" data-url=\"https://seekingalpha.com/news/3523500-zscalerminus-5_6-on-weak-q2-view\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523496\" data-ts=\"1575408698\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RAPT\" target=\"_blank\">RAPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523496-rapt-teams-up-hanmi-on-flx475-in-asia-shares-up-12-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RAPT teams up with Hanmi on FLX475 in Asia; shares up 12% after hours</a></h4><ul><li>RAPT Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/RAPT' title='RAPT Therapeutics, Inc.'>RAPT</a>) will <a href=\"https://seekingalpha.com/pr/17717227-rapt-therapeutics-and-hanmi-pharmaceutical-announce-collaboration-to-develop-and\" target=\"_blank\">collaborate </a>with South Korea's Hanmi Pharmaceutical Co., Ltd. to develop and commercialize cancer candidate FLX475, a CCR4 antagonist, in Asia.</li><li>Under the terms of the agreement, RAPT will receive $10M upfront, up to $48M in development milestones, up to $60M in sales milestones and double-digit royalties on net sales. Hanmi will have an exclusive license to FLX475 in South Korea and China (including Taiwan and Hong Kong).</li><li>Shares up <font color=\"green\">12%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523496\" data-linked=\"RAPT teams up with Hanmi on FLX475 in Asia; shares up 12% after hours\" data-tweet=\"$RAPT - RAPT teams up with Hanmi on FLX475 in Asia; shares up 12% after hours https://seekingalpha.com/news/3523496-rapt-teams-up-hanmi-on-flx475-in-asia-shares-up-12-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3523496-rapt-teams-up-hanmi-on-flx475-in-asia-shares-up-12-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:31 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523490\" data-ts=\"1575408146\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRM\" target=\"_blank\">CRM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523490-salesforceminus-1_7-after-downside-eps-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Salesforce -1.7% after downside EPS outlook</a></h4><ul><li>Salesforce (NYSE:<a href='https://seekingalpha.com/symbol/CRM' title='salesforce.com, inc.'>CRM</a>) <font color=\"red\">-1.7%</font> reports <a href=\"https://seekingalpha.com/news/3523469-salesforce-com-eps-beats-0_09-beats-on-revenue\" target=\"_blank\">Q3 beats</a> with a mixed Q4 outlook that sees upside revenue of $4.74-4.75B (consensus: $4.73B) and downside EPS of $0.54-0.55 (consensus: $0.61).</li><li>The in-line Q1 outlook sees revenue of $4.8-4.84B.</li><li>For FY20, CRM reiterates its revenue guidance of $16.9-17B and raises its EPS view to $2.89-2.90 from $2.80-2.84.</li><li>Q3 subscription and support revenue was $4.24B, up 34% Y/Y. Professional services and other grew 22% to $274M.</li><li>Cash from operations totaled $298M (+108% Y/Y), and Salesforce ended the quarter with $6.53B in cash and equivalents.</li><li>The remaining performance obligation was up 22% to $26B. The current remaining obligation was up 28% to $12.8B.</li><li>Earnings call starts at 5 PM with a webcast <a href=\"https://c212.net/c/link/?t=0&amp;l=en&amp;o=2659464-1&amp;h=1443442830&amp;u=http%3A%2F%2Fwww.salesforce.com%2Finvestor&amp;a=www.salesforce.com%2Finvestor\" target=\"_blank\">here</a>.</li><li><a href=\"https://seekingalpha.com/pr/17717232-salesforce-announces-record-third-quarter-fiscal-2020-results\" target=\"_blank\">Press release</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523490\" data-linked=\"Salesforce -1.7% after downside EPS outlook\" data-tweet=\"$CRM - Salesforce -1.7% after downside EPS outlook https://seekingalpha.com/news/3523490-salesforceminus-1_7-after-downside-eps-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3523490-salesforceminus-1_7-after-downside-eps-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523488\" data-ts=\"1575407789\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RLMD\" target=\"_blank\">RLMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523488-relmada-launches-equity-offering-shares-down-5-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Relmada launches equity offering; shares down 5% after hours</a></h4><ul><li>Relmada Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/RLMD' title='Relmada Therapeutics, Inc.'>RLMD</a>) <a href=\"https://seekingalpha.com/pr/17717240-relmada-therapeutics-announces-proposed-public-offering-of-common-stock\" target=\"_blank\">initiates </a>a public offering of common stock. Price, volume and terms have yet to be announced.</li><li>Shares down <font color=\"red\">5%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523488\" data-linked=\"Relmada launches equity offering; shares down 5% after hours\" data-tweet=\"$RLMD - Relmada launches equity offering; shares down 5% after hours https://seekingalpha.com/news/3523488-relmada-launches-equity-offering-shares-down-5-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3523488-relmada-launches-equity-offering-shares-down-5-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523483\" data-ts=\"1575407620\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADMS\" target=\"_blank\">ADMS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523483-adamas-pharma-inks-50m-stock-sales-deal-cowen\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Adamas Pharma inks $50M stock sales deal with Cowen</a></h4><ul><li>Adamas Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ADMS' title='Adamas Pharmaceuticals, Inc.'>ADMS</a>) slips <font color=\"red\">1%</font> after hours on the heels of its <a href=\"https://www.sec.gov/Archives/edgar/data/1328143/000132814319000059/admsform424b5atm12219.htm\" target=\"_blank\">agreement </a>with Cowen and Company for the at-the-market sale of up to $50M of its common stock. Cowen will earn a 3% commission for its efforts.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523483\" data-linked=\"Adamas Pharma inks $50M stock sales deal with Cowen\" data-tweet=\"$ADMS - Adamas Pharma inks $50M stock sales deal with Cowen https://seekingalpha.com/news/3523483-adamas-pharma-inks-50m-stock-sales-deal-cowen?source=tweet\" data-url=\"https://seekingalpha.com/news/3523483-adamas-pharma-inks-50m-stock-sales-deal-cowen\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523475\" data-ts=\"1575407389\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RVNC\" target=\"_blank\">RVNC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523475-revance-launches-equity-offering-shares-down-11-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Revance launches equity offering; shares down 11% after hours</a></h4><ul><li>Revance Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/RVNC' title='Revance Therapeutics, Inc.'>RVNC</a>) <a href=\"https://seekingalpha.com/pr/17717189-revance-announces-proposed-public-offering-of-common-stock\" target=\"_blank\">initiates </a>a public offering of common stock. Price, volume and terms have yet to be released.</li><li>Shares down <font color=\"red\">11%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523475\" data-linked=\"Revance launches equity offering; shares down 11% after hours\" data-tweet=\"$RVNC - Revance launches equity offering; shares down 11% after hours https://seekingalpha.com/news/3523475-revance-launches-equity-offering-shares-down-11-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3523475-revance-launches-equity-offering-shares-down-11-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:09 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523473\" data-ts=\"1575407324\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WDAY\" target=\"_blank\">WDAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523473-workdayplus-1-after-upside-q3-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Workday +1% after upside Q3 report</a></h4><ul><li>Workday (NASDAQ:<a href='https://seekingalpha.com/symbol/WDAY' title='Workday, Inc.'>WDAY</a>)<font color=\"green\"> +1%</font> reports<a href=\"https://seekingalpha.com/news/3523462-workday-eps-beats-0_16-beats-on-revenue\" target=\"_blank\"> Q3 beats</a> with subscription revenue up 28% Y/Y to $798.5M and professional services revenue up 18% to $139.6M.</li><li>Subscription revenue backlog rose 22% to $7.19B.</li><li>The adjusted operating margin was 15.2%, up from last year's 6.7%.</li><li>Operating cash flows rose from $114.3M in 2018 to $258M.</li><li>Earnings call starts at 4:30 PM with a webcast <a href=\"https://edge.media-server.com/mmc/p/grzkbfuu\" target=\"_blank\">here</a>.</li><li><a href=\"https://seekingalpha.com/pr/17717190-workday-announces-fiscal-2020-third-quarter-financial-results\" target=\"_blank\">Press release</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523473\" data-linked=\"Workday +1% after upside Q3 report\" data-tweet=\"$WDAY - Workday +1% after upside Q3 report https://seekingalpha.com/news/3523473-workdayplus-1-after-upside-q3-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3523473-workdayplus-1-after-upside-q3-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523471\" data-ts=\"1575407294\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMMU\" target=\"_blank\">IMMU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523471-immunomedics-readies-250m-equity-offering-shares-down-4-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Immunomedics readies $250M equity offering; shares down 4% after hours</a></h4><ul><li>Immunomedics (NASDAQ:<a href='https://seekingalpha.com/symbol/IMMU' title='Immunomedics, Inc.'>IMMU</a>) slips <font color=\"red\">4%</font> after hours in reaction to its <a href=\"https://seekingalpha.com/pr/17717193-immunomedics-announces-proposed-public-offering-of-common-stock\" target=\"_blank\">$250M public offering</a> of common stock. Price, volume and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523471\" data-linked=\"Immunomedics readies $250M equity offering; shares down 4% after hours\" data-tweet=\"$IMMU - Immunomedics readies $250M equity offering; shares down 4% after hours https://seekingalpha.com/news/3523471-immunomedics-readies-250m-equity-offering-shares-down-4-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3523471-immunomedics-readies-250m-equity-offering-shares-down-4-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523467\" data-ts=\"1575407154\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDRX\" target=\"_blank\">MDRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523467-allscripts-launches-200m-convertible-debt-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Allscripts launches $200M convertible debt offering</a></h4><ul><li>Allscripts Healthcare Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/MDRX' title='Allscripts Healthcare Solutions, Inc.'>MDRX</a>) slips <font color=\"red\">1%</font> after hours on the heels of its <a href=\"https://seekingalpha.com/pr/17717204-allscripts-announces-200-million-convertible-senior-notes-offering\" target=\"_blank\">$200M private offering</a> of convertible senior notes due 2027. Initial buyers will have a 13-day option to purchase up to an additional $30M of the notes.</li><li>Price, yield and conversion rate have yet to be determined.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523467\" data-linked=\"Allscripts launches $200M convertible debt offering\" data-tweet=\"$MDRX - Allscripts launches $200M convertible debt offering https://seekingalpha.com/news/3523467-allscripts-launches-200m-convertible-debt-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3523467-allscripts-launches-200m-convertible-debt-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523463\" data-ts=\"1575407039\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HQY\" target=\"_blank\">HQY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523463-healthequity-eps-beats-0_24-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">HealthEquity EPS beats by $0.24, beats on revenue</a></h4><ul><li>HealthEquity (NASDAQ:<a href='https://seekingalpha.com/symbol/HQY' title='HealthEquity, Inc.'>HQY</a>): Q3 Non-GAAP EPS of $0.47 <font color=\"green\">beats by $0.24</font>; GAAP EPS of -$0.30 <font color=\"red\">misses by $0.04</font>.</li><li>Revenue of $157.12M (+122.9% Y/Y) <font color=\"green\">beats by $4.74M</font>.</li><li>Shares <font color=\"green\">+5.3%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17717182-healthequity-reports-strong-third-quarter-results-raises-business-outlook\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3523463\" data-linked=\"HealthEquity EPS beats by $0.24, beats on revenue\" data-tweet=\"$HQY - HealthEquity EPS beats by $0.24, beats on revenue https://seekingalpha.com/news/3523463-healthequity-eps-beats-0_24-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3523463-healthequity-eps-beats-0_24-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523462\" data-ts=\"1575407001\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WDAY\" target=\"_blank\">WDAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523462-workday-eps-beats-0_16-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Workday EPS beats by $0.16, beats on revenue</a></h4><ul><li>Workday (NASDAQ:<a href='https://seekingalpha.com/symbol/WDAY' title='Workday, Inc.'>WDAY</a>): Q3 Non-GAAP EPS of $0.53 <font color=\"green\">beats by $0.16</font>; GAAP EPS of -$0.51 <font color=\"green\">beats by $0.14</font>.</li><li>Revenue of $938.1M (+26.2% Y/Y) <font color=\"green\">beats by $17.45M</font>.</li><li>Shares <font color=\"green\">+1.4%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17717190-workday-announces-fiscal-2020-third-quarter-financial-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3523462\" data-linked=\"Workday EPS beats by $0.16, beats on revenue\" data-tweet=\"$WDAY - Workday EPS beats by $0.16, beats on revenue https://seekingalpha.com/news/3523462-workday-eps-beats-0_16-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3523462-workday-eps-beats-0_16-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523460\" data-ts=\"1575406583\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UNG\" target=\"_blank\">UNG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523460-natural-gas-gains-on-colder-weather-forecasts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Natural gas gains on colder weather forecasts</a></h4><ul><li>Natural gas futures (<a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a> <font color='green'>+4.3%</font>) close <font color=\"green\">+4.8%</font> to $2.44/MMBtu after some climate models <a href=\"https://www.wsj.com/articles/natural-gas-jumps-on-colder-weather-forecasts-11575395023\" target=\"_blank\">predicted a sweep of cold weather</a> across the Midwest and eastern two-thirds of the U.S. within the next two weeks.</li><li>Some analysts are not convinced today's gain will last; Ritterbusch and Associates says it is \"not yet seeing any below-normal [temperature] expectations and in the absence of such forecasts, additional price gains will likely prove limited.\"</li><li>Today's boost comes after the natural gas price plunged nearly 16% last week for its largest weekly decline in more than a decade, hurt by ample supply levels and milder than expected temperatures.</li><li>While most energy equities are down, natural gas-focused names trade higher today: <a href='https://seekingalpha.com/symbol/CHK' title='Chesapeake Energy Corporation'>CHK</a> <font color=\"green\">+5.1%</font>, <a href='https://seekingalpha.com/symbol/AR' title='Antero Resources Corporation'>AR</a> <font color=\"green\">+4%</font>, <a href='https://seekingalpha.com/symbol/RRC' title='Range Resources Corporation'>RRC</a> <font color=\"green\">+1.5%</font>, <a href='https://seekingalpha.com/symbol/EQT' title='EQT Corporation'>EQT</a> <font color=\"green\">+1%</font>, <a href='https://seekingalpha.com/symbol/GPOR' title='Gulfport Energy Corporation'>GPOR</a> <font color=\"green\">+1%</font>, <a href='https://seekingalpha.com/symbol/SWN' title='Southwestern Energy Company'>SWN</a> <font color=\"green\">+0.8%</font>, <a href='https://seekingalpha.com/symbol/COG' title='Cabot Oil & Gas Corporation'>COG</a> <font color=\"red\">-1.6%</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a>, <a href='https://seekingalpha.com/symbol/UGAZ' title='VelocityShares 3x Long Natural Gas ETN'>UGAZ</a>, <a href='https://seekingalpha.com/symbol/DGAZ' title='VelocityShares 3x Inverse Natural Gas ETN'>DGAZ</a>, <a href='https://seekingalpha.com/symbol/BOIL' title='ProShares Trust II - ProShares Ultra Bloomberg Natural Gas'>BOIL</a>, <a href='https://seekingalpha.com/symbol/GASL' title='Direxion Daily Natural Gas Related Bull 3x Shares ETF'>GASL</a>, <a href='https://seekingalpha.com/symbol/FCG' title='First Trust Natural Gas ETF'>FCG</a>, <a href='https://seekingalpha.com/symbol/KOLD' title='ProShares Trust II - ProShares UltraShort Bloomberg Natural Gas'>KOLD</a>, <a href='https://seekingalpha.com/symbol/GASX' title='Direxion Daily Natural Gas Related Bear 3X Shares ETF'>GASX</a>, <a href='https://seekingalpha.com/symbol/UNL' title='United States 12 Month Natural Gas Fund, LP'>UNL</a>, <a href='https://seekingalpha.com/symbol/GAZB' title='iPath Series B Bloomberg Natural Gas Subindex Total Return ETN'>GAZB</a>, <a href='https://seekingalpha.com/symbol/GAZ' title='iPath Series B Bloomberg Natural Gas Subindex Total Return ETN'>GAZ</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3523460\" data-linked=\"Natural gas gains on colder weather forecasts\" data-tweet=\"$UNG $CHK $AR - Natural gas gains on colder weather forecasts https://seekingalpha.com/news/3523460-natural-gas-gains-on-colder-weather-forecasts?source=tweet\" data-url=\"https://seekingalpha.com/news/3523460-natural-gas-gains-on-colder-weather-forecasts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>29&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523459\" data-ts=\"1575405713\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VAL\" target=\"_blank\">VAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523459-valaris-cut-to-neutral-from-buy-btig-on-slower-forecast-recovery\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Valaris cut to Neutral from Buy at BTIG on slower than forecast recovery</a></h4><ul><li>Valaris (<a href='https://seekingalpha.com/symbol/VAL' title='Valaris plc'>VAL</a> <font color='red'>-6.2%</font>) plummets as BTIG <a href=\"https://thefly.com/thestreet/realmoney/index.php/VALid3000940/VAL-Valaris-downgraded-to-Neutral-from-Buy-at-BTIG\" target=\"_blank\">downgrades</a> shares to Neutral from Buy, saying that the offshore drilling recovery is underway but the pace of the recovery has been slower than expected.</li><li>BTIG's Gregory Lewis says the 10 contracts VAL announced last week \"only\" increased its backlog by $285M, while the analyst expected the contracts to generate backlog  closer to $350M based on implied market rates, adding he sees \"no quick fix\"  for the company.</li><li>VAL's average <a href=\"https://seekingalpha.com/symbol/VAL/ratings/sell-side-ratings\" target=\"_blank\">Sell Side Rating</a>, <a href=\"https://seekingalpha.com/symbol/VAL/ratings/author-ratings#filter=all\" target=\"_blank\">Seeking Alpha Authors' Rating</a> and <a href=\"https://seekingalpha.com/symbol/VAL/ratings/quant-ratings\" target=\"_blank\">Quant Rating</a> are all Neutral.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523459\" data-linked=\"Valaris cut to Neutral from Buy at BTIG on slower than forecast recovery\" data-tweet=\"$VAL - Valaris cut to Neutral from Buy at BTIG on slower than forecast recovery https://seekingalpha.com/news/3523459-valaris-cut-to-neutral-from-buy-btig-on-slower-forecast-recovery?source=tweet\" data-url=\"https://seekingalpha.com/news/3523459-valaris-cut-to-neutral-from-buy-btig-on-slower-forecast-recovery\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>53&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523452\" data-ts=\"1575404850\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XLV\" target=\"_blank\">XLV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523452-averages-stage-modest-bounce-attempt\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Averages stage modest bounce attempt</a></h4><ul><li>A bit more than 30 minutes before the close, the averages are well off their worst levels of the session, with the Nasdaq <font color=\"red\">down 0.6% </font>and S&amp;P 500 <font color=\"red\">0.8%</font>. The DJIA is <font color=\"red\">off 1%</font>.</li><li>The day's best-performing sectors are the defensive ones, with the health care SPDR (<a href='https://seekingalpha.com/symbol/XLV' title='Health Care Select Sect SPDR ETF'>XLV</a> <font color='red'>-0.3%</font>) and consumer staples SPDR (<a href='https://seekingalpha.com/symbol/XLP' title='Consumer Staples Select Sector SPDR ETF'>XLP</a> <font color='red'>-0.4%</font>) down just modestly, and the utilities (<a href='https://seekingalpha.com/symbol/XLU' title='Utilities Select Sector SPDR ETF'>XLU</a> <font color='green'>+0.4%</font>) in the green.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523452\" data-linked=\"Averages stage modest bounce attempt\" data-tweet=\"$XLV $XLP $XLU - Averages stage modest bounce attempt https://seekingalpha.com/news/3523452-averages-stage-modest-bounce-attempt?source=tweet\" data-url=\"https://seekingalpha.com/news/3523452-averages-stage-modest-bounce-attempt\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523451\" data-ts=\"1575404774\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OTLK\" target=\"_blank\">OTLK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523451-outlook-therapeutics-up-49-on-advancement-of-onsminus-5010\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Outlook Therapeutics up 49% on advancement of ONS-5010</a></h4><ul><li>Thinly traded nano cap Outlook Therapeutics (<a href='https://seekingalpha.com/symbol/OTLK' title='Outlook Therapeutics, Inc.'>OTLK</a> <font color=\"green\">+49.3%</font>) is up on a healthy 24x surge in volume on the heels of the FDA's <a href=\"https://seekingalpha.com/pr/17716139-outlook-therapeutics-receives-fda-agreement-for-three-special-protocol-assessments-for\" target=\"_blank\">sign-off</a> on protocols for three new Phase 3 studies supporting ONS-5010, an ophthalmic formulation of Roche's cancer med Avastin (bevacizumab).</li><li>The three studies are: NORSE 4, in patients with branch retinal vein occlusion &#40;BRVO&#41; and NORSE 5 &amp; 6 in diabetic macular edema patients. All should launch in 2020 after enrollment is completed in <a href=\"https://clinicaltrials.gov/ct2/show/NCT03834753?lead=outlook+therapeutics&amp;phase=2&amp;draw=2&amp;rank=2\" target=\"_blank\">NORSE 2</a> in wet AMD. If all goes well, the company expects to launch commercially in 2022.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523451\" data-linked=\"Outlook Therapeutics up 49% on advancement of ONS-5010\" data-tweet=\"$OTLK - Outlook Therapeutics up 49% on advancement of ONS-5010 https://seekingalpha.com/news/3523451-outlook-therapeutics-up-49-on-advancement-of-onsminus-5010?source=tweet\" data-url=\"https://seekingalpha.com/news/3523451-outlook-therapeutics-up-49-on-advancement-of-onsminus-5010\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523449\" data-ts=\"1575404633\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GLD\" target=\"_blank\">GLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523449-gold-closes-nearly-one-month-high-on-safe-haven-trade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gold closes at nearly one-month high on safe-haven trade</a></h4><ul><li>Gold futures (<a href='https://seekingalpha.com/symbol/GLD' title='SPDR Gold Trust ETF'>GLD</a> <font color='green'>+1%</font>) rose to their <a href=\"https://www.marketwatch.com/story/gold-boosted-after-trump-suggests-china-trade-deal-could-wait-till-after-2020-election-2019-12-03\" target=\"_blank\">highest mark in nearly a month</a>, enjoying safe-haven buying interest after Pres. Trump said a U.S.-China trade deal could wait until after the November 2020 presidential election.</li><li>February Comex gold settled <font color=\"green\">+1%</font> to $1,484.40/oz., the highest settlement for a most-active contract since Nov. 6, while March silver ended <font color=\"green\">+1.7%</font> at $17.24/oz.</li><li>\"There is <a href=\"https://www.cnbc.com/2019/12/03/gold-markets-latin-american-tariffs-in-focus.html\" target=\"_blank\">flight to safety in gold</a> right now,\" says Bob Haberkorn, senior  market strategist at RJO Futures. \"All signs point towards a move back  above $1,485 on the February contract, which could be enough to push it  above $1,500.\"</li><li>Among precious metals mining stocks: <a href='https://seekingalpha.com/symbol/HMY' title='Harmony Gold Mining Company Limited'>HMY</a> <font color=\"green\">+10.6%</font>, <a href='https://seekingalpha.com/symbol/GFI' title='Gold Fields Limited'>GFI</a> <font color=\"green\">+8.3%</font>, <a href='https://seekingalpha.com/symbol/SBGL' title='Sibanye Gold Limited'>SBGL</a> <font color=\"green\">+8.3%</font>, <a href='https://seekingalpha.com/symbol/HL' title='Hecla Mining Company'>HL</a> <font color=\"green\">+8.3%</font>, <a href='https://seekingalpha.com/symbol/EXK' title='Endeavour Silver Corp.'>EXK</a> <font color=\"green\">+7%</font>, <a href='https://seekingalpha.com/symbol/AU' title='AngloGold Ashanti Limited'>AU</a> <font color=\"green\">+5.4%</font>, <a href='https://seekingalpha.com/symbol/FSM' title='Fortuna Silver Mines Inc.'>FSM</a> <font color=\"green\">+4.1%</font>, <a href='https://seekingalpha.com/symbol/KGC' title='Kinross Gold Corporation'>KGC</a> <font color=\"green\">+3.6%</font>, <a href='https://seekingalpha.com/symbol/PAAS' title='Pan American Silver Corp.'>PAAS</a> <font color=\"green\">+2.6%</font>, <a href='https://seekingalpha.com/symbol/AG' title='First Majestic Silver Corp.'>AG</a> <font color=\"green\">+2.6%</font>, <a href='https://seekingalpha.com/symbol/AEM' title='Agnico Eagle Mines Limited'>AEM</a> <font color=\"green\">+2.3%</font>, <a href='https://seekingalpha.com/symbol/GOLD' title='Barrick Gold Corporation'>GOLD</a> <font color=\"green\">+1.9%</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/GLD' title='SPDR Gold Trust ETF'>GLD</a>, <a href='https://seekingalpha.com/symbol/SLV' title='iShares Silver Trust ETF'>SLV</a>, <a href='https://seekingalpha.com/symbol/GDX' title='VanEck Vectors Gold Miners ETF'>GDX</a>, <a href='https://seekingalpha.com/symbol/NUGT' title='Direxion Daily Gold Miners Index Bull 3x Shares ETF'>NUGT</a>, <a href='https://seekingalpha.com/symbol/IAU' title='iShares Gold Trust ETF'>IAU</a>, <a href='https://seekingalpha.com/symbol/GGN' title='GAMCO Global Gold, Natural Resources & Income Trust'>GGN</a>, <a href='https://seekingalpha.com/symbol/DUST' title='Direxion Daily Gold Miners Index Bear 3x Shares ETF'>DUST</a>, <a href='https://seekingalpha.com/symbol/SIL' title='Global X Silver Miners ETF'>SIL</a>, <a href='https://seekingalpha.com/symbol/USLV' title='VelocityShares 3x Long Silver ETN'>USLV</a>, <a href='https://seekingalpha.com/symbol/AGQ' title='ProShares Ultra Silver ETF'>AGQ</a>, <a href='https://seekingalpha.com/symbol/PSLV' title='Sprott Physical Silver Trust'>PSLV</a>, <a href='https://seekingalpha.com/symbol/PHYS' title='Sprott Physical Gold Trust'>PHYS</a>, <a href='https://seekingalpha.com/symbol/SIVR' title='Aberd Std Silvr Shs'>SIVR</a>, <a href='https://seekingalpha.com/symbol/UGLD' title='VelocityShares 3x Long Gold ETN'>UGLD</a>, <a href='https://seekingalpha.com/symbol/SGOL' title='Aberdn Std Gold Shs'>SGOL</a>, <a href='https://seekingalpha.com/symbol/GOEX' title='Global X Gold Explorers ETF'>GOEX</a>, <a href='https://seekingalpha.com/symbol/SGDM' title='Sprott Gold Miners ETF'>SGDM</a>, <a href='https://seekingalpha.com/symbol/UGL' title='ProShares Ultra Gold ETF'>UGL</a>, <a href='https://seekingalpha.com/symbol/ASA' title='ASA Gold&Precious Metals'>ASA</a>, <a href='https://seekingalpha.com/symbol/ZSL' title='ProShares Trust II - ProShares UltraShort Silver'>ZSL</a>, <a href='https://seekingalpha.com/symbol/BAR' title='GraniteShares Gold Trust'>BAR</a>, <a href='https://seekingalpha.com/symbol/SLVO' title='Credit Suisse Silver Shares Covered Call ETN'>SLVO</a>, <a href='https://seekingalpha.com/symbol/DGP' title='DB Gold Double Long ETN'>DGP</a>, <a href='https://seekingalpha.com/symbol/RING' title='iShares MSCI Global Gold Miners ETF'>RING</a>, <a href='https://seekingalpha.com/symbol/GLDI' title='Credit Suisse Gold Shares Covered Call ETN'>GLDI</a>, <a href='https://seekingalpha.com/symbol/DSLV' title='VelocityShares 3x Inverse Silver ETN'>DSLV</a>, <a href='https://seekingalpha.com/symbol/SLVP' title='iShares, Inc. - iShares MSCI Global Silver Miners ETF'>SLVP</a>, <a href='https://seekingalpha.com/symbol/GLDM' title='World Gold Trust - SPDR Gold MiniShares Trust'>GLDM</a>, <a href='https://seekingalpha.com/symbol/OUNZ' title='VanEck Merk Gold Trust'>OUNZ</a>, <a href='https://seekingalpha.com/symbol/GLL' title='ProShares UltraShort Gold ETF'>GLL</a>, <a href='https://seekingalpha.com/symbol/AAAU' title='Perth Mint Physical Gold ETF'>AAAU</a>, <a href='https://seekingalpha.com/symbol/GOAU' title='U.S. Global GO GOLD and Precious Metal Miners ETF'>GOAU</a>,</li></ul><div class=\"tiny-share-widget\" data-id=\"3523449\" data-linked=\"Gold closes at nearly one-month high on safe-haven trade\" data-tweet=\"$GLD $HMY $GFI - Gold closes at nearly one-month high on safe-haven trade https://seekingalpha.com/news/3523449-gold-closes-nearly-one-month-high-on-safe-haven-trade?source=tweet\" data-url=\"https://seekingalpha.com/news/3523449-gold-closes-nearly-one-month-high-on-safe-haven-trade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>33&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523444\" data-ts=\"1575403217\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523444-wrap-technologies-and-mosys-among-tech-gainers-cootek-and-safe-t-group-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wrap Technologies and MoSys among Tech gainers; CooTek and Safe-T Group among losers</a></h4><ul><li><b>Gainers: </b>Wrap Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/WRTC' title='Wrap Technologies, Inc.'>WRTC</a>) <font color=\"green\">+15%</font>. MoSys (NASDAQ:<a href='https://seekingalpha.com/symbol/MOSY' title='MoSys, Inc.'>MOSY</a>) <font color=\"green\">+9%</font>. My Size (NASDAQ:<a href='https://seekingalpha.com/symbol/MYSZ' title='My Size, Inc.'>MYSZ</a>) <font color=\"green\">+8%</font>. Enphase Energy (NASDAQ:<a href='https://seekingalpha.com/symbol/ENPH' title='Enphase Energy, Inc.'>ENPH</a>) <font color=\"green\">+8%</font>. Sunworks (NASDAQ:<a href='https://seekingalpha.com/symbol/SUNW' title='Sunworks, Inc.'>SUNW</a>) <font color=\"green\">+8%</font>.</li><li><b>Losers: </b>CooTek (NYSE:<a href='https://seekingalpha.com/symbol/CTK' title='CooTek &#40;Cayman&#41; Inc.'>CTK</a>) <font color=\"red\">-18%</font>. Safe-T Group (NASDAQ:<a href='https://seekingalpha.com/symbol/SFET' title='Safe-T Group Ltd'>SFET</a>) <font color=\"red\">-13%</font>. Tufin Software Technologies (NYSE:<a href='https://seekingalpha.com/symbol/TUFN' title='Tufin Software Technologies Ltd.'>TUFN</a>) <font color=\"red\">-13%</font>. Resonant (NASDAQ:<a href='https://seekingalpha.com/symbol/RESN' title='Resonant Inc.'>RESN</a>) <font color=\"red\">-11%</font>. TTEC (NASDAQ:<a href='https://seekingalpha.com/symbol/TTEC' title='TTEC Holdings, Inc.'>TTEC</a>) <font color=\"red\">-10%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523444\" data-linked=\"Wrap Technologies and MoSys among Tech gainers; CooTek and Safe-T Group among losers\" data-tweet=\"$WRTC $MOSY $MYSZ - Wrap Technologies and MoSys among Tech gainers; CooTek and Safe-T Group among losers https://seekingalpha.com/news/3523444-wrap-technologies-and-mosys-among-tech-gainers-cootek-and-safe-t-group-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3523444-wrap-technologies-and-mosys-among-tech-gainers-cootek-and-safe-t-group-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523443\" data-ts=\"1575403095\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BMO\" target=\"_blank\">BMO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523443-bmo-unveils-plans-to-cut-5-of-global-workforce-takes-357m-charge\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BMO unveils plans to cut 5% of global workforce, takes $357M charge</a></h4><ul><li>Bank of Montreal (<a href='https://seekingalpha.com/symbol/BMO' title='Bank of Montreal'>BMO</a> <font color='red'>-2.4%</font>) limps to its lowest level in three months after <a href=\"https://seekingalpha.com/news/3523249-bank-of-montreal-eps-beats-c-0_02-beats-on-revenue\" target=\"_blank\">Q4 earnings</a> fell to $1.19B, hit by a  $357M restructuring charge related primarily to severance that will affect 5% of its global workforce.</li><li>BMO did not disclose details about where or when the job cuts would occur, but the bank had ~45.5K employees at the end of October, so a 5% cut <a href=\"https://www.cbc.ca/news/business/bank-of-montreal-q4-1.5382312\" target=\"_blank\">suggests 2,275 jobs would be affected.</a></li><li>CFO Tom Flynn says the bank's efficiency initiatives announced today will save $200M in its  2020 financial year, which began Nov. 1, and $375M by Q1 of its 2021 financial year.</li><li>\"Our financial objectives remain unchanged,\" CEO Darryl White says. \"Our goals over the  medium-term are to achieve average earnings per share growth of 7%-10%.\"</li><li>\"In Canada, we expect macroeconomic conditions to remain  constructive in 2020, improving modestly from 2019 with stable interest  rates and unemployment running at a four decade low of 5.6%. In  the U.S., we expect economic activity to slow modestly in 2020 in  response to trade protectionism,\" White says.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523443\" data-linked=\"BMO unveils plans to cut 5% of global workforce, takes $357M charge\" data-tweet=\"$BMO - BMO unveils plans to cut 5% of global workforce, takes $357M charge https://seekingalpha.com/news/3523443-bmo-unveils-plans-to-cut-5-of-global-workforce-takes-357m-charge?source=tweet\" data-url=\"https://seekingalpha.com/news/3523443-bmo-unveils-plans-to-cut-5-of-global-workforce-takes-357m-charge\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523442\" data-ts=\"1575402170\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTON\" target=\"_blank\">PTON</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523442-raymond-james-defends-peloton\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Raymond James defends Peloton</a></h4><ul><li>Raymond James is sticking with an Outperform rating on Peloton (<a href='https://seekingalpha.com/symbol/PTON' title='Peloton Interactive, Inc.'>PTON</a> <font color='red'>-8.6%</font>), despite the backlash against the company's \"The Gift that Gives Back\" ad campaign.</li><li>Analyst Justin Patterson thinks the ad will be pulled due to the online furor and notes Peloton is no stranger to memes poking fun at it. Perhaps more importantly, Peloton Black Friday traffic was reported appeared to be solid, which bodes well for the two-month holiday period sales tally.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3523314-peloton-ad-goes-viral\" target=\"_blank\">Peloton ad goes viral</a> (Dec. 3)</li></ul><div class=\"tiny-share-widget\" data-id=\"3523442\" data-linked=\"Raymond James defends Peloton\" data-tweet=\"$PTON - Raymond James defends Peloton https://seekingalpha.com/news/3523442-raymond-james-defends-peloton?source=tweet\" data-url=\"https://seekingalpha.com/news/3523442-raymond-james-defends-peloton\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523437\" data-ts=\"1575401468\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FCX\" target=\"_blank\">FCX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523437-freeport-mcmoran-under-pressure-amid-trade-worries\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Freeport-McMoRan under pressure amid trade worries</a></h4><ul><li>Freeport McMoRan (<a href='https://seekingalpha.com/symbol/FCX' title='Freeport-McMoRan Inc.'>FCX</a> <font color=\"red\">-5.6%</font>) is one of the two worst performers today on the S&amp;P 500, slammed by <a href=\"https://seekingalpha.com/news/3523337-stocks-down-1-trump-suggests-trade-deal-wait\" target=\"_blank\">renewed worries</a> that a U.S.-China trade deal may not happen until after the 2020 election, if at all.</li><li>Copper is widely used in industrial applications, so the latest trade news has sparked concerns that FCX shares have run up too much with a 36% gain off its Oct. 9 low, and copper futures today <font color=\"red\">-1%</font> to $2.63/lb. as growth concerns feed worries about supply-demand imbalances.</li><li>Technical selling pressure also may be a factor, as today's loss has sent the stock below its 200-day moving average of 11.05/share.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523437\" data-linked=\"Freeport-McMoRan under pressure amid trade worries\" data-tweet=\"$FCX - Freeport-McMoRan under pressure amid trade worries https://seekingalpha.com/news/3523437-freeport-mcmoran-under-pressure-amid-trade-worries?source=tweet\" data-url=\"https://seekingalpha.com/news/3523437-freeport-mcmoran-under-pressure-amid-trade-worries\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523429\" data-ts=\"1575400234\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLF\" target=\"_blank\">CLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523429-cleveland-cliffs-plunges-ak-steel-rallies-on-deal-reaction\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cleveland-Cliffs plunges, AK Steel rallies on deal reaction</a></h4><ul><li>Cleveland-Cliffs (<a href='https://seekingalpha.com/symbol/CLF' title='Cleveland-Cliffs Inc.'>CLF</a> <font color='red'>-12%</font>) shares are primed for their steepest decline in three months after <a href=\"https://seekingalpha.com/news/3523270-cleveland-cliffs-buys-ak-steel-in-1_1b-stock-deal\" target=\"_blank\">agreeing to buy</a> AK Steel (<a href='https://seekingalpha.com/symbol/AKS' title='AK Steel Holding Corporation'>AKS</a> <font color='green'>+3.5%</font>) for $1.1B.</li><li><a href=\"https://finance.yahoo.com/news/top-u-iron-ore-miner-163359589.html\" target=\"_blank\">The deal is \"expensive\"</a> because it values AKS at 8.5x next year's estimated EBITDA, higher than its peers, says BMO analyst David Gagliano.</li><li>AKS has a total debt of $2.24B as of the end of Q3, placing it at 3.81x the company's trailing 12-month EBITDA, higher than CLF's 3.55x.</li><li>CEO Lourenco Goncalves' \"track record of successfully executing turnarounds at Cliffs and Metals USA bodes well for the combination, though it's possible the deal was done more to lock up a home for Cliffs' future pellet offtake, while providing a lifeline to AK Steel,\" Bloomberg analyst Richard Bourke writes.</li><li>\"We do not foresee a competing bid nor antitrust issues for the proposed CLF-AKS deal, but CLF may have some work ahead to win over shareholders,\" Jefferies analysts say.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523429\" data-linked=\"Cleveland-Cliffs plunges, AK Steel rallies on deal reaction\" data-tweet=\"$CLF $AKS - Cleveland-Cliffs plunges, AK Steel rallies on deal reaction https://seekingalpha.com/news/3523429-cleveland-cliffs-plunges-ak-steel-rallies-on-deal-reaction?source=tweet\" data-url=\"https://seekingalpha.com/news/3523429-cleveland-cliffs-plunges-ak-steel-rallies-on-deal-reaction\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>54&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523425\" data-ts=\"1575399677\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523425-alexco-resource-and-harmony-gold-mining-among-energy-materials-gainers-cleveland-cliffs-and\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alexco Resource and Harmony Gold Mining among Energy/Materials gainers; Cleveland-Cliffs and Rosehill Resources among losers</a></h4><ul><li><b>Gainers: </b>Alexco Resource (NYSEMKT:<a href='https://seekingalpha.com/symbol/AXU' title='Alexco Resource Corp.'>AXU</a>) <font color=\"green\">+10%</font>. Harmony Gold Mining (NYSE:<a href='https://seekingalpha.com/symbol/HMY' title='Harmony Gold Mining Company Limited'>HMY</a>) <font color=\"green\">+9%</font>. Sibanye Gold (NYSE:<a href='https://seekingalpha.com/symbol/SBGL' title='Sibanye Gold Limited'>SBGL</a>) <font color=\"green\">+8%</font>. Hecla Mining (NYSE:<a href='https://seekingalpha.com/symbol/HL' title='Hecla Mining Company'>HL</a>) <font color=\"green\">+8%</font>. Coeur Mining (NYSE:<a href='https://seekingalpha.com/symbol/CDE' title='Coeur Mining, Inc.'>CDE</a>) <font color=\"green\">+8%</font>.</li><li><b>Losers: </b>Cleveland-Cliffs (NYSE:<a href='https://seekingalpha.com/symbol/CLF' title='Cleveland-Cliffs Inc.'>CLF</a>) <font color=\"red\">-11%</font>. Rosehill Resources (NASDAQ:<a href='https://seekingalpha.com/symbol/ROSE' title='Rosehill Resources Inc.'>ROSE</a>) <font color=\"red\">-8%</font>. Venator Materials (NYSE:<a href='https://seekingalpha.com/symbol/VNTR' title='Venator Materials PLC'>VNTR</a>) <font color=\"red\">-8%</font>. Tronox (NYSE:<a href='https://seekingalpha.com/symbol/TROX' title='Tronox Holdings plc'>TROX</a>) <font color=\"red\">-8%</font>. Lightbridge (NASDAQ:<a href='https://seekingalpha.com/symbol/LTBR' title='Lightbridge Corporation'>LTBR</a>) <font color=\"red\">-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523425\" data-linked=\"Alexco Resource and Harmony Gold Mining among Energy/Materials gainers; Cleveland-Cliffs and Rosehill Resources among losers\" data-tweet=\"$AXU $HMY $SBGL - Alexco Resource and Harmony Gold Mining among Energy/Materials gainers; Cleveland-Cliffs and Rosehill Resources among losers https://seekingalpha.com/news/3523425-alexco-resource-and-harmony-gold-mining-among-energy-materials-gainers-cleveland-cliffs-and?source=tweet\" data-url=\"https://seekingalpha.com/news/3523425-alexco-resource-and-harmony-gold-mining-among-energy-materials-gainers-cleveland-cliffs-and\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523422\" data-ts=\"1575398878\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBRL\" target=\"_blank\">CBRL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523422-argus-cools-on-cracker-barrel\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Argus cools on Cracker Barrel</a></h4><ul><li>Argus lowers Cracker Barrel Old Country Store (<a href='https://seekingalpha.com/symbol/CBRL' title='Cracker Barrel Old Country Store, Inc.'>CBRL</a> <font color='red'>-2.7%</font>) to a Hold rating after having it set at Buy.</li><li>\"Looking ahead, we expect margins and earnings to face pressure as comp sales slow and the company adds fewer new stores,\" writes analyst John Staszak.</li><li>\"We also expect Cracker Barrel to have difficulty cutting costs in the near term due to rising wages and commodity costs. Based on these challenges, we believe that CBRL shares are fairly valued at 17.9-times our revised FY20 estimate.\"</li><li>Argus lowers its FY20 EPS estimate on Cracker Barrel to $8.75 from $9.88 and FY21 estimate to $9.50 from $10.70.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523422\" data-linked=\"Argus cools on Cracker Barrel\" data-tweet=\"$CBRL - Argus cools on Cracker Barrel https://seekingalpha.com/news/3523422-argus-cools-on-cracker-barrel?source=tweet\" data-url=\"https://seekingalpha.com/news/3523422-argus-cools-on-cracker-barrel\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523419\" data-ts=\"1575398507\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523419-bat-group-only-financial-gainer-cbl-associates-properties-leads-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bat Group the only financial gainer; CBL &amp; Associates Properties leads losers</a></h4><ul><li><b>Gainers:</b> Bat Group (NASDAQ:<a href='https://seekingalpha.com/symbol/GLG' title='Bat Group, Inc.'>GLG</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers:</b> CBL &amp; Associates Properties (NYSE:<a href='https://seekingalpha.com/symbol/CBL' title='CBL & Associates Properties, Inc'>CBL</a>) <font color=\"red\">-26%</font>. CPI Card Group (NASDAQ:<a href='https://seekingalpha.com/symbol/PMTS' title='CPI Card Group Inc.'>PMTS</a>) <font color=\"red\">-16%</font>. MoneyGram International (NASDAQ:<a href='https://seekingalpha.com/symbol/MGI' title='MoneyGram International, Inc.'>MGI</a>) <font color=\"red\">-8%</font>. China Rapid Finance (NYSE:<a href='https://seekingalpha.com/symbol/XRF' title='China Rapid Finance Limited'>XRF</a>) <font color=\"red\">-8%</font>. Scully Royalty (NYSE:<a href='https://seekingalpha.com/symbol/SRL' title='Scully Royalty Ltd.'>SRL</a>) <font color=\"red\">-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523419\" data-linked=\"Bat Group the only financial gainer; CBL &amp; Associates Properties leads losers\" data-tweet=\"$GLG $CBL $PMTS - Bat Group the only financial gainer; CBL &amp; Associates Properties leads losers https://seekingalpha.com/news/3523419-bat-group-only-financial-gainer-cbl-associates-properties-leads-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3523419-bat-group-only-financial-gainer-cbl-associates-properties-leads-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:41 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523415\" data-ts=\"1575397477\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BCEL\" target=\"_blank\">BCEL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523415-atreca-up-25-on-advancement-of-lead-candidate\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Atreca up 25% on advancement of lead candidate</a></h4><ul><li>Thinly traded micro cap Atreca (<a href='https://seekingalpha.com/symbol/BCEL' title='Atreca, Inc.'>BCEL</a> <font color=\"green\">+24.8%</font>) is up on more than double normal volume, albeit on turnover of only 262K shares, in apparent reaction to the <a href=\"https://seekingalpha.com/pr/17716097-atreca-announces-fda-clearance-of-investigational-new-drug-application-for-atrcminus-101\" target=\"_blank\">FDA's sign-off</a> on its IND for lead candidate ATRC-101. A Phase 1b study in patients with solid tumors should commence next quarter.</li><li>ATRC-101 is a monoclonal antibody with a novel mechanism of action that the company calls Driver Antigen Engagement, meaning that the systemic delivery of the antibody engages the innate immune system, causing remodeling of the tumor microenvironment and the destruction of cancer cells by T cells.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523415\" data-linked=\"Atreca up 25% on advancement of lead candidate\" data-tweet=\"$BCEL - Atreca up 25% on advancement of lead candidate https://seekingalpha.com/news/3523415-atreca-up-25-on-advancement-of-lead-candidate?source=tweet\" data-url=\"https://seekingalpha.com/news/3523415-atreca-up-25-on-advancement-of-lead-candidate\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:24 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523414\" data-ts=\"1575397148\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FUJHY\" target=\"_blank\">FUJHY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523414-subaru-u-s-sales-rise-0_2-in-november\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Subaru U.S. sales rise 0.2% in November</a></h4><ul> <li>Subaru (<a href='https://seekingalpha.com/symbol/FUJHY' title='Subaru Corporation'>OTCPK:FUJHY</a>) unit sales <a href=\"https://seekingalpha.com/pr/17717022-subaru-of-america-reports-record-november-sales\" sasource=\"qp_sum_news_1\" target=\"_blank\">+0.2%</a> to 56,893 units in November.</li><li>Sales growth by model: Ascent +28% to 7,545 units; Forester +2% to 16,386 units; Outback -7.1% to 12,481 units; Crosstrek -2.3% to 10,378 units.</li><li>YTD Subaru U.S. sales advanced 3.6% to 637,753 units.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523414\" data-linked=\"Subaru U.S. sales rise 0.2% in November\" data-tweet=\"$FUJHY $FUJHF - Subaru U.S. sales rise 0.2% in November https://seekingalpha.com/news/3523414-subaru-u-s-sales-rise-0_2-in-november?source=tweet\" data-url=\"https://seekingalpha.com/news/3523414-subaru-u-s-sales-rise-0_2-in-november\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523412\" data-ts=\"1575396895\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/POAHF\" target=\"_blank\">POAHF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523412-porsche-reports-11_5-rise-in-u-s-retail-sales-november\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Porsche reports 11.5% rise in U.S. retail sales November</a></h4><ul><li>Porsche (<a href='https://seekingalpha.com/symbol/POAHF' title='Porsche Automobil Holding SE Preferred Shares'>OTCPK:POAHF</a>) unit sales rose <a href=\"https://seekingalpha.com/pr/17717024-porsche-reports-u-s-retail-sales-for-november\" sasource=\"qp_sum_news_1\" target=\"_blank\">11.5%</a> to 6,326 units in November.</li><li>911 sales fell 7.3% to 979 units.</li><li>718 sales dropped 41.5% to 247 units</li><li>Cayenne sales increased 52.4% to 1,972 units.</li><li>Panamera sales declined 17.9% to 657 units.</li><li>Macan sales expanded 17.6% to 2,471 units.</li><li>YTD Porsche U.S. sales up 7% to 56,835 units.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523412\" data-linked=\"Porsche reports 11.5% rise in U.S. retail sales November\" data-tweet=\"$POAHF $POAHY - Porsche reports 11.5% rise in U.S. retail sales November https://seekingalpha.com/news/3523412-porsche-reports-11_5-rise-in-u-s-retail-sales-november?source=tweet\" data-url=\"https://seekingalpha.com/news/3523412-porsche-reports-11_5-rise-in-u-s-retail-sales-november\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:14 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523409\" data-ts=\"1575396264\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HMC\" target=\"_blank\">HMC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523409-american-honda-salesplus-11_1-in-november\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Honda sales +11.1% in November</a></h4><ul><li>Honda (<a href='https://seekingalpha.com/symbol/HMC' title='Honda Motor Co., Ltd.'>HMC</a> <font color='red'>-0.3%</font>) unit sales <a href=\"https://seekingalpha.com/pr/17716895-strong-car-truck-sales-fuel-record-november-for-american-honda-and-honda-and-acura-trucks\" sasource=\"qp_sum_news_14\" target=\"_blank\">+11.1%</a> to 133,952 units.</li><li>Sales rose 2.2% for cars and 18.2% for trucks.</li><li>Sales in the Honda division up 12.2% to 119,470 units and Acura sales +3.1% to 14,482 units.</li><li>Civic sales increased 8.2% and Accord sales down 7% for the month.</li><li>YTD Honda sales grew 1.5% to 1,471,604 units.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523409\" data-linked=\"American Honda sales +11.1% in November\" data-tweet=\"$HMC $HNDAF - American Honda sales +11.1% in November https://seekingalpha.com/news/3523409-american-honda-salesplus-11_1-in-november?source=tweet\" data-url=\"https://seekingalpha.com/news/3523409-american-honda-salesplus-11_1-in-november\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:04 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523408\" data-ts=\"1575396260\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523408-hebron-technology-only-industrial-gainer-plug-power-leads-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hebron Technology only industrial gainer; Plug Power leads the losers</a></h4><ul><li><b>Gainers: </b>Hebron Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/HEBT' title='Hebron Technology Co., Ltd.'>HEBT</a>) <font color=\"green\">+7%</font>.</li><li><b>Losers: </b>Plug Power (NASDAQ:<a href='https://seekingalpha.com/symbol/PLUG' title='Plug Power Inc.'>PLUG</a>) <font color=\"red\">-12%</font>. Capstone Turbine (NASDAQ:<a href='https://seekingalpha.com/symbol/CPST' title='Capstone Turbine Corporation'>CPST</a>) <font color=\"red\">-7%</font>. CVD Equipment (NASDAQ:<a href='https://seekingalpha.com/symbol/CVV' title='CVD Equipment Corporation'>CVV</a>) <font color=\"red\">-7%</font>. Astrotech (NASDAQ:<a href='https://seekingalpha.com/symbol/ASTC' title='Astrotech Corporation'>ASTC</a>) <font color=\"red\">-6%</font>. Clarivate Analytics (NYSE:<a href='https://seekingalpha.com/symbol/CCC' title='Clarivate Analytics Plc'>CCC</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523408\" data-linked=\"Hebron Technology only industrial gainer; Plug Power leads the losers\" data-tweet=\"$HEBT $PLUG $CPST - Hebron Technology only industrial gainer; Plug Power leads the losers https://seekingalpha.com/news/3523408-hebron-technology-only-industrial-gainer-plug-power-leads-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3523408-hebron-technology-only-industrial-gainer-plug-power-leads-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:04 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523407\" data-ts=\"1575395801\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HYMLF\" target=\"_blank\">HYMLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523407-hyundai-u-s-sales-grew-6-in-november\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hyundai U.S. sales grew 6% in November</a></h4><ul><li>Hyundai (<a href='https://seekingalpha.com/symbol/HYMLF' title='Hyundai Motor Company'>OTCPK:HYMLF</a>) reports sales in the U.S. rose <a href=\"https://seekingalpha.com/pr/17716507-hyundai-motor-america-reports-november-2019-sales\" sasource=\"qp_sum_news_3\" target=\"_blank\">6%</a> in November to 60,601 units.</li><li>Hyundai's retail sales increased a significant 19%, the second straight month with double-digit retail growth.</li><li>YTD Hyundai U.S. sales up 3.6% to 624,051 units.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523407\" data-linked=\"Hyundai U.S. sales grew 6% in November\" data-tweet=\"$HYMLF $HYMOF $HYMPF - Hyundai U.S. sales grew 6% in November https://seekingalpha.com/news/3523407-hyundai-u-s-sales-grew-6-in-november?source=tweet\" data-url=\"https://seekingalpha.com/news/3523407-hyundai-u-s-sales-grew-6-in-november\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:56 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523403\" data-ts=\"1575395079\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523403-cbl-cara-vray-and-bold-among-midday-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CBL, CARA, VRAY and BOLD among midday movers</a></h4><ul><li><strong>Gainers: </strong>Audentes Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/BOLD' title='Audentes Therapeutics, Inc.'>BOLD</a>) <font color=\"green\">+105%</font>.</li><li>DarioHealth (NASDAQ:<a href='https://seekingalpha.com/symbol/DRIO' title='DarioHealth Corp.'>DRIO</a>) <font color=\"green\">+50%</font>.</li><li>ViewRay (NASDAQ:<a href='https://seekingalpha.com/symbol/VRAY' title='ViewRay, Inc.'>VRAY</a>) <font color=\"green\">+35%</font>.</li><li>Outlook Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/OTLK' title='Outlook Therapeutics, Inc.'>OTLK</a>) <font color=\"green\">+34%</font>.</li><li>Calyxt (NASDAQ:<a href='https://seekingalpha.com/symbol/CLXT' title='Calyxt, Inc.'>CLXT</a>) <font color=\"green\">+29%</font>.</li><li>Iterum Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ITRM' title='Iterum Therapeutics plc'>ITRM</a>) <font color=\"green\">+24%</font>.</li><li>Akerna (NASDAQ:<a href='https://seekingalpha.com/symbol/KERN' title='Akerna Corp.'>KERN</a>) <font color=\"green\">+24%</font>.</li><li>Atreca (NASDAQ:<a href='https://seekingalpha.com/symbol/BCEL' title='Atreca, Inc.'>BCEL</a>) <font color=\"green\">+22%</font>.</li><li>Lands' End (NASDAQ:<a href='https://seekingalpha.com/symbol/LE' title='Lands&#39; End, Inc.'>LE</a>) <font color=\"green\">+18%</font>.</li><li>Wrap Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/WRTC' title='Wrap Technologies, Inc.'>WRTC</a>) <font color=\"green\">+13%</font>.</li><li><strong>Losers:</strong> ASLAN Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ASLN' title='ASLAN Pharmaceuticals Limited'>ASLN</a>) <font color=\"red\">-47%</font>.</li><li>Protagonist Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/PTGX' title='Protagonist Therapeutics, Inc.'>PTGX</a>) <font color=\"red\">-41%</font>.</li><li>Aldeyra Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ALDX' title='Aldeyra Therapeutics, Inc.'>ALDX</a>) <font color=\"red\">-31%</font>.</li><li>Cara Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/CARA' title='Cara Therapeutics, Inc.'>CARA</a>) <font color=\"red\">-29%</font>.</li><li>CBL &amp; Associates Properties (NYSE:<a href='https://seekingalpha.com/symbol/CBL' title='CBL & Associates Properties, Inc'>CBL</a>) <font color=\"red\">-27%</font>.</li><li>Eyenovia (NASDAQ:<a href='https://seekingalpha.com/symbol/EYEN' title='Eyenovia, Inc.'>EYEN</a>) <font color=\"red\">-16%</font>.</li><li>CooTek (NYSE:<a href='https://seekingalpha.com/symbol/CTK' title='CooTek &#40;Cayman&#41; Inc.'>CTK</a>) <font color=\"red\">-14%</font>.</li><li>Duluth (NASDAQ:<a href='https://seekingalpha.com/symbol/DLTH' title='Duluth Holdings Inc.'>DLTH</a>) <font color=\"red\">-14%</font>.</li><li>Liquid Media (NASDAQ:<a href='https://seekingalpha.com/symbol/YVR' title='Liquid Media Group Ltd.'>YVR</a>) <font color=\"red\">-13%</font>.</li><li>CPI Card (NASDAQ:<a href='https://seekingalpha.com/symbol/PMTS' title='CPI Card Group Inc.'>PMTS</a>) <font color=\"red\">-12%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523403\" data-linked=\"CBL, CARA, VRAY and BOLD among midday movers\" data-tweet=\"$BOLD $DRIO $VRAY - CBL, CARA, VRAY and BOLD among midday movers https://seekingalpha.com/news/3523403-cbl-cara-vray-and-bold-among-midday-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3523403-cbl-cara-vray-and-bold-among-midday-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523402\" data-ts=\"1575394997\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523402-u-s-considered-banning-huawei-from-financial-system-reuters\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.S. considered banning Huawei from financial system - Reuters</a></h4><ul>   <li>The Trump administration this year had considered <a href=\"https://www.reuters.com/article/us-huawei-tech-usa-treasury-exclusive/exclusive-white-house-considered-kicking-huawei-out-of-u-s-banking-system-sources-idUSKBN1Y717U\" target=\"_blank\">banning Huawei from the U.S. financial system</a>, Reuters reports, as part of its policy arsenal lined up against the Chinese equipment maker.</li>    <li>A move to put Huawei on the Specially Designated Nationals list - a \"nuclear option\" among sanctions - was shelved at the time but could be revived in coming months, according to the report.</li>    <li>Placing Huawei on that list would make it virtually impossible for Huawei to complete transactions in U.S. dollars, though it would spur numerous logistical, diplomatic and economic challenges for the U.S. (including hurting allies that already rely on Huawei).</li>    <li>The news is the latest following warnings from the United States to other countries not to buy telecom gear from Huawei and ZTE (<a href=\"http://seekingalpha.com/symbol/ZTCOF\" target=\"_blank\">ZTCOF</a> <font color=\"red\">-1.7%</font>), an effort that will now get real funding. A newly created U.S. International Development Finance Corp. will use part of a $60B budget to help developing countries and their businesses to buy rival equipment.</li>    <li>Such a severe move would mean a clear benefit for rival equipment makers Nokia (NYSE:<a href='https://seekingalpha.com/symbol/NOK' title='Nokia Corporation'>NOK</a>) and Ericsson (<a href=\"http://seekingalpha.com/symbol/ERIC\" target=\"_blank\">ERIC</a> <font color=\"green\">+2.2%</font>).</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3523402\" data-linked=\"U.S. considered banning Huawei from financial system - Reuters\" data-tweet=\"$NOK $ZTCOF $ERIC - U.S. considered banning Huawei from financial system - Reuters https://seekingalpha.com/news/3523402-u-s-considered-banning-huawei-from-financial-system-reuters?source=tweet\" data-url=\"https://seekingalpha.com/news/3523402-u-s-considered-banning-huawei-from-financial-system-reuters\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523398\" data-ts=\"1575394294\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADAP\" target=\"_blank\">ADAP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523398-adaptimmunes-adp-a2m4-nabs-rmat-tag-for-rare-soft-tissue-cancer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Adaptimmune&#39;s ADP-A2M4 nabs RMAT tag for rare soft tissue cancer</a></h4><ul><li>The FDA <a href=\"https://seekingalpha.com/pr/17716263-regenerative-medicine-advanced-therapy-designation-granted-fda-to-adp-a2m4-for-treatment-of\" target=\"_blank\">designates </a>Adaptimmune Therapeutics' (<a href='https://seekingalpha.com/symbol/ADAP' title='Adaptimmune Therapeutics plc'>ADAP</a> <font color=\"green\">+0.8%</font>) T-cell therapy <a href=\"https://www.adaptimmune.com/pipeline/adp-a2m4\" target=\"_blank\">ADP-A2M4</a> a Regenerative Medicine Advanced Therapy &#40;RMAT&#41; for the treatment of synovial sarcoma, a rare type of soft tissue cancer, also an Orphan Drug indication in the U.S.</li><li>RMAT, akin to Breakthrough Therapy status for drugs/biologics, provides for the accelerated review of the marketing application and more intensive guidance on development.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523398\" data-linked=\"Adaptimmune&#39;s ADP-A2M4 nabs RMAT tag for rare soft tissue cancer\" data-tweet=\"$ADAP - Adaptimmune&#39;s ADP-A2M4 nabs RMAT tag for rare soft tissue cancer https://seekingalpha.com/news/3523398-adaptimmunes-adp-a2m4-nabs-rmat-tag-for-rare-soft-tissue-cancer?source=tweet\" data-url=\"https://seekingalpha.com/news/3523398-adaptimmunes-adp-a2m4-nabs-rmat-tag-for-rare-soft-tissue-cancer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523397\" data-ts=\"1575394097\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BAND\" target=\"_blank\">BAND</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523397-bandwidthplus-2_5-after-needham-launch-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bandwidth +2.5% after Needham launch at Buy</a></h4><ul>   <li>After a slow start, Bandwidth (NASDAQ:<a href='https://seekingalpha.com/symbol/BAND' title='Bandwidth Inc.'>BAND</a>) is <font color=\"green\">up 2.5%</font> following its initiation at Buy by Needham.</li>    <li>The firm's Richard Valera has set a price target of $65, now implying 19% upside.</li>    <li>That comes amid a recent wave of <a href=\"https://seekingalpha.com/symbol/BAND/ratings/sell-side-ratings\" target=\"_blank\">price target cuts</a> from analysts.</li>    <li>Overall, sell-side analysts are <a href=\"https://seekingalpha.com/symbol/BAND/ratings/sell-side-ratings\" target=\"_blank\">Bullish on the shares</a>, and <a href=\"https://seekingalpha.com/symbol/BAND/ratings/author-ratings\" target=\"_blank\">Seeking Alpha authors are Very Bullish</a>. The stock has a <a href=\"https://seekingalpha.com/symbol/BAND/ratings/quant-ratings\" target=\"_blank\">Quant Rating of Neutral</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3523397\" data-linked=\"Bandwidth +2.5% after Needham launch at Buy\" data-tweet=\"$BAND - Bandwidth +2.5% after Needham launch at Buy https://seekingalpha.com/news/3523397-bandwidthplus-2_5-after-needham-launch-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3523397-bandwidthplus-2_5-after-needham-launch-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:28 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523396\" data-ts=\"1575393851\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MACK\" target=\"_blank\">MACK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523396-merrimack-pharma-up-6-on-6_7m-special-dividend\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Merrimack Pharma up 6% on $6.7M special dividend</a></h4><ul><li>Thinly traded nano cap Merrimack Pharmaceuticals (<a href='https://seekingalpha.com/symbol/MACK' title='Merrimack Pharmaceuticals, Inc.'>MACK</a> <font color=\"green\">+6.1%</font>) is up on almost 30% higher volume, albeit on turnover of only 66K shares, on the heels of its <a href=\"https://seekingalpha.com/pr/17716375-merrimack-receives-5-million-milestone-payment-from-ipsen-declares-6_7-million-special\" target=\"_blank\">announcement</a> that it has received a $5M milestone payment from Ipsen S.A. (<a href='https://seekingalpha.com/symbol/IPSEY' title='Ipsen S.A.'>OTCPK:IPSEY</a>) triggered by the latter's decision to advance the ongoing clinical trial evaluating Onivyde (irinotecan liposome injection) in small-cell lung cancer patients.</li><li>As a result, Merrimack's board has authorized and declared a $6.7M special cash dividend to shareholders of record on December 16 (ex-dividend date is December 13). The payout will be ~$0.50 per share.</li><li>Ipsen <a href=\"https://seekingalpha.com/news/3234027-ipsen-to-acquire-oncology-assets-from-merrimack\" target=\"_blank\">acquired </a>the company's oncology assets almost three years ago for $575M in cash plus potential payments for new indications of Onivyde.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523396\" data-linked=\"Merrimack Pharma up 6% on $6.7M special dividend\" data-tweet=\"$MACK $IPSEY $IPSEF - Merrimack Pharma up 6% on $6.7M special dividend https://seekingalpha.com/news/3523396-merrimack-pharma-up-6-on-6_7m-special-dividend?source=tweet\" data-url=\"https://seekingalpha.com/news/3523396-merrimack-pharma-up-6-on-6_7m-special-dividend\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:24 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523394\" data-ts=\"1575393406\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VWAGY\" target=\"_blank\">VWAGY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523394-another-raid-volkswagen-hq\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Another raid at Volkswagen HQ</a></h4><ul> <li>Volkswagen (<a href='https://seekingalpha.com/symbol/VWAGY' title='Volkswagen AG ADR'>OTCPK:VWAGY</a>) is the target of another raid related to the diesel emissions scandal, with public prosecutors storming the Wolfsburg headquarters today to search for documents.</li> <li>The search was reportedly targeted against certain individuals and their relation to disclosures about EA288 diesel engines.</li> <li>Shares of Volkswagen are <font color=\"red\">down 0.88%</font> in Frankfurt trading.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3523394\" data-linked=\"Another raid at Volkswagen HQ\" data-tweet=\"$VWAGY - Another raid at Volkswagen HQ https://seekingalpha.com/news/3523394-another-raid-volkswagen-hq?source=tweet\" data-url=\"https://seekingalpha.com/news/3523394-another-raid-volkswagen-hq\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523391\" data-ts=\"1575392760\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTEC\" target=\"_blank\">NTEC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523391-intec-pharma-up-11-on-10m-stock-purchase-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intec Pharma up 11% on $10M stock purchase deal</a></h4><ul><li>Nano cap Intec Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/NTEC' title='Intec Pharma Ltd.'>NTEC</a>) is up <font color=\"green\">11%</font> on below-average volume on the heels of its stock purchase <a href=\"https://seekingalpha.com/pr/17716004-intec-pharma-announces-10-million-ordinary-shares-purchase-agreement-aspire-capital\" target=\"_blank\">agreement</a> with Aspire Capital Fund, LLC, under which the latter will purchase up to $10M of the company's ordinary shares over a 30-month period at Intec's discretion.</li><li>Aspire will receive 612,520 ordinary shares as a commitment fee.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523391\" data-linked=\"Intec Pharma up 11% on $10M stock purchase deal\" data-tweet=\"$NTEC - Intec Pharma up 11% on $10M stock purchase deal https://seekingalpha.com/news/3523391-intec-pharma-up-11-on-10m-stock-purchase-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3523391-intec-pharma-up-11-on-10m-stock-purchase-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:06 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523388\" data-ts=\"1575392420\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523388-vuzix-among-consumer-gainers-adient-and-tenneco-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vuzix among consumer gainers; Adient and Tenneco among losers</a></h4><ul><li><b>Gainers: </b>Calyxt (NASDAQ:<a href='https://seekingalpha.com/symbol/CLXT' title='Calyxt, Inc.'>CLXT</a>) <font color=\"green\">+34%</font>. Vuzix (NASDAQ:<a href='https://seekingalpha.com/symbol/VUZI' title='Vuzix Corporation'>VUZI</a>) <font color=\"green\">+7%</font>. Unique Fabricating (NYSEMKT:<a href='https://seekingalpha.com/symbol/UFAB' title='Unique Fabricating, Inc.'>UFAB</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>e.l.f. Beauty (NYSE:<a href='https://seekingalpha.com/symbol/ELF' title='e.l.f. Beauty, Inc.'>ELF</a>) <font color=\"red\">-7%</font>. Adient (NYSE:<a href='https://seekingalpha.com/symbol/ADNT' title='Adient plc'>ADNT</a>) <font color=\"red\">-7%</font>. Peloton Interactive (NASDAQ:<a href='https://seekingalpha.com/symbol/PTON' title='Peloton Interactive, Inc.'>PTON</a>) <font color=\"red\">-7%</font>. Tenneco (NYSE:<a href='https://seekingalpha.com/symbol/TEN' title='Tenneco Inc.'>TEN</a>) <font color=\"red\">-7%</font>. Fuwei Films (NASDAQ:<a href='https://seekingalpha.com/symbol/FFHL' title='Fuwei Films &#40;Holdings&#41; Co., Ltd.'>FFHL</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523388\" data-linked=\"Vuzix among consumer gainers; Adient and Tenneco among losers\" data-tweet=\"$CLXT $VUZI $UFAB - Vuzix among consumer gainers; Adient and Tenneco among losers https://seekingalpha.com/news/3523388-vuzix-among-consumer-gainers-adient-and-tenneco-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3523388-vuzix-among-consumer-gainers-adient-and-tenneco-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523386\" data-ts=\"1575392380\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523386-amd-intc-dip-amazon-unveils-graviton2-processor\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AMD, INTC dip as Amazon unveils Graviton2 processor</a></h4><ul><li>Amazon (<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a> <font color=\"red\">-1.6%</font>)<a href=\"https://aws.amazon.com/blogs/aws/coming-soon-graviton2-powered-general-purpose-compute-optimized-memory-optimized-ec2-instances/?sc_channel=sm&amp;sc_campaign=launch_reInvent&amp;sc_publisher=TWITTER&amp;sc_country=Global&amp;sc_outcome=awareness&amp;trk=AWS_reInvent_2019_launch__TWITTER&amp;sc_content=AWS_reInvent_2019_launch_&amp;linkId=78151855\" target=\"_blank\"> unveils</a> its new Graviton2, a custom AWS cloud processor chip that could take on Intel (<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a> <font color=\"red\">-2.7%</font>) and AMD (<a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a> <font color=\"red\">-1.4%</font>).</li><li>The 7nm chip is based on 64-bit Arm Neoverse cores. Amazon says the processors <a href=\"https://aws.amazon.com/ec2/graviton/\" target=\"_blank\">offer</a> up to 40% better performance from comparable x86-based instances with a 20% lower cost.</li><li>Graviton2 has a 2x faster floating-point performance per core for scientific and high-performance workloads. The processor can support up to 64 virtual CPUs, 25 Gbps of networking, and 18 Gbps of EBS Bandwidth.</li><li>AWS services like Amazon Elastic Load Balancing, Amazon ElastiCache, and Amazon Elastic Map Reduce have tested the instances and will move into production next year.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523386\" data-linked=\"AMD, INTC dip as Amazon unveils Graviton2 processor\" data-tweet=\"$AMZN $INTC $AMD - AMD, INTC dip as Amazon unveils Graviton2 processor https://seekingalpha.com/news/3523386-amd-intc-dip-amazon-unveils-graviton2-processor?source=tweet\" data-url=\"https://seekingalpha.com/news/3523386-amd-intc-dip-amazon-unveils-graviton2-processor\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>149&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523389\" data-ts=\"1575392364\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XLF\" target=\"_blank\">XLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523389-tariff-fears-sink-financial-stocks-10-year-treasury-yield-tumbles-14-bps\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tariff fears sink financial stocks; 10-year Treasury yield tumbles 14 bps</a></h4><ul><li><a href=\"https://www.marketwatch.com/story/financial-stocks-sink-as-tariff-fears-send-treasury-yields-tumbling-the-most-in-over-3-years-2019-12-03\" target=\"_blank\">Bank stocks take a beating</a>, as renewed trade war fears send the 10-year Treasury yield tumbling toward its biggest decline in more than three years.</li><li>The 10-year yield has fallen 14 basis points to 1.69%, on track for the biggest one-day basis-point drop since shedding 16 bps on June 24, 2016.</li><li>The SPDR Financial Select ETF (<a href='https://seekingalpha.com/symbol/XLF' title='Financial Select Sector SPDR ETF'>XLF</a> <font color=\"red\">-2%</font>) is the weakest of the S&amp;P 500's 11 sectors, with 65 of the 67 stocks trading in the red.</li><li>Among XLF's noteworthy decliners: <a href='https://seekingalpha.com/symbol/GS' title='The Goldman Sachs Group, Inc.'>GS</a> <font color=\"red\">-3.4%</font>, <a href='https://seekingalpha.com/symbol/MS' title='Morgan Stanley'>MS</a> <font color=\"red\">-3.2%</font>, <a href='https://seekingalpha.com/symbol/BAC' title='Bank of America Corporation'>BAC</a> <font color=\"red\">-2.6%</font>, <a href='https://seekingalpha.com/symbol/WFC' title='Wells Fargo & Company'>WFC</a> <font color=\"red\">-2.5%</font>, <a href='https://seekingalpha.com/symbol/C' title='Citigroup Inc.'>C</a> <font color=\"red\">-2.4%</font>, <a href='https://seekingalpha.com/symbol/JPM' title='JPMorgan Chase & Co.'>JPM</a> <font color=\"red\">-2.1%</font>, <a href='https://seekingalpha.com/symbol/COF' title='Capital One Financial Corporation'>COF</a> <font color=\"red\">-2.1%</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/TLT' title='iShares 20+ Year Treasury Bond ETF'>TLT</a>, <a href='https://seekingalpha.com/symbol/XLF' title='Financial Select Sector SPDR ETF'>XLF</a>, <a href='https://seekingalpha.com/symbol/TBT' title='ProShares UltraShort 20+ Year Treasury ETF'>TBT</a>, <a href='https://seekingalpha.com/symbol/FAS' title='Direxion Daily Financial Bull 3x Shares ETF'>FAS</a>, <a href='https://seekingalpha.com/symbol/FAZ' title='Direxion Daily Financial Bear 3x Shares ETF'>FAZ</a>, <a href='https://seekingalpha.com/symbol/VFH' title='Vanguard Financials ETF'>VFH</a>, <a href='https://seekingalpha.com/symbol/TMV' title='Direxion Daily 20+ Year Treasury Bear 3x Shares ETF'>TMV</a>, <a href='https://seekingalpha.com/symbol/EDV' title='Vanguard Extended Duration Treasury ETF'>EDV</a>, <a href='https://seekingalpha.com/symbol/TMF' title='Direxion Daily 30-Year Treasury Bull 3x Shares ETF'>TMF</a>, <a href='https://seekingalpha.com/symbol/VGLT' title='Vanguard Long-Term Treasury ETF'>VGLT</a>, <a href='https://seekingalpha.com/symbol/TBF' title='ProShares Short 20+ Year Treasury ETF'>TBF</a>, <a href='https://seekingalpha.com/symbol/UYG' title='ProShares Ultra Financials ETF'>UYG</a>, <a href='https://seekingalpha.com/symbol/FNCL' title='Fidelity Covington Trust - Fidelity MSCI Financials Index ETF'>FNCL</a>, <a href='https://seekingalpha.com/symbol/SPTL' title='SPDR Portfolio Long Term Treasury ETF'>SPTL</a>, <a href='https://seekingalpha.com/symbol/BTO' title='John Hancock Financial Opportunity Fund'>BTO</a>, <a href='https://seekingalpha.com/symbol/IYF' title='iShares U.S. Financials ETF'>IYF</a>, <a href='https://seekingalpha.com/symbol/ZROZ' title='PIMCO ETF Trust - PIMCO 25+ Year Zero Coupon U.S. Treasury Index Exchange-Traded Fund'>ZROZ</a>, <a href='https://seekingalpha.com/symbol/TTT' title='ProShares Trust - ProShares UltraPro Short 20+ Year Treasury'>TTT</a>, <a href='https://seekingalpha.com/symbol/TLH' title='iShares 10-20 Year Treasury Bond ETF'>TLH</a>, <a href='https://seekingalpha.com/symbol/IYG' title='iShares U.S. Financial Services ETF'>IYG</a>, <a href='https://seekingalpha.com/symbol/FINU' title='ProShares Trust - ProShares UltraPro Financial Select Sector'>FINU</a>, <a href='https://seekingalpha.com/symbol/FXO' title='First Trust Financials AlphaDEX ETF'>FXO</a>, <a href='https://seekingalpha.com/symbol/RYF' title='Invesco Exchange-Traded Fund Trust - Invesco S&P 500 Equal Weight Financials ETF'>RYF</a>, <a href='https://seekingalpha.com/symbol/UBT' title='ProShares Trust - ProShares Ultra 20+ Year Treasury'>UBT</a>, <a href='https://seekingalpha.com/symbol/VUSTX' title='Vanguard Long Term Treasury Fund Inv'>VUSTX</a>, <a href='https://seekingalpha.com/symbol/SEF' title='ProShares Short Financials ETF'>SEF</a>, <a href='https://seekingalpha.com/symbol/DLBS' title='iPath US Treasury Long Bond Bear ETN'>DLBS</a>, <a href='https://seekingalpha.com/symbol/PFI' title='Invesco Exchange-Traded Fund Trust - Invesco DWA Financial Momentum ETF'>PFI</a>, <a href='https://seekingalpha.com/symbol/FINZ' title='ProShares UltraPro Short Financials ETF'>FINZ</a>, <a href='https://seekingalpha.com/symbol/RWW' title='Oppenheimer Financials Sector Revenue ETF'>RWW</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3523389\" data-linked=\"Tariff fears sink financial stocks; 10-year Treasury yield tumbles 14 bps\" data-tweet=\"$XLF $GS $MS - Tariff fears sink financial stocks; 10-year Treasury yield tumbles 14 bps https://seekingalpha.com/news/3523389-tariff-fears-sink-financial-stocks-10-year-treasury-yield-tumbles-14-bps?source=tweet\" data-url=\"https://seekingalpha.com/news/3523389-tariff-fears-sink-financial-stocks-10-year-treasury-yield-tumbles-14-bps\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>106&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523385\" data-ts=\"1575392172\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COMM\" target=\"_blank\">COMM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523385-commscope-realigning-four-segments\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CommScope realigning into four segments</a></h4><ul>   <li>CommScope (<a href=\"http://seekingalpha.com/symbol/COMM\" target=\"_blank\">COMM</a> <font color=\"red\">-3.5%</font>) will <a href=\"https://seekingalpha.com/pr/17716908-commscope-to-realign-four-business-segments-in-2020\" target=\"_blank\">realign into four business segments</a> for the new year, transitioning to a new operating/reporting structure on Jan. 1.</li>    <li>The move is to better capture the strategic value from its acquisitions of Arris and Ruckus Networks.</li>    <li>The four segments will be Venue and Campus Networks; Broadband Networks; Outdoor Wireless Networks; and Home Networks.</li>    <li>\u201cWe expect our new operating model will enable us to realize significant benefits of cost and revenue synergies, strengthen our technology leadership, and support our long-term growth strategy,\" says CEO Eddie Edwards.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3523385\" data-linked=\"CommScope realigning into four segments\" data-tweet=\"$COMM - CommScope realigning into four segments https://seekingalpha.com/news/3523385-commscope-realigning-four-segments?source=tweet\" data-url=\"https://seekingalpha.com/news/3523385-commscope-realigning-four-segments\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523384\" data-ts=\"1575392133\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BTAI\" target=\"_blank\">BTAI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523384-bioxcel-up-5-on-advancement-of-bxcl501\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BioXcel up 5% on advancement of BXCL501</a></h4><ul><li>Thinly traded micro cap BioXcel Therapeutics (<a href='https://seekingalpha.com/symbol/BTAI' title='BioXcel Therapeutics, Inc.'>BTAI</a> <font color=\"green\">+5%</font>) is up, albeit on modest turnover of 29K shares, in reaction to its <a href=\"https://seekingalpha.com/pr/17715965-bioxcel-therapeutics-prepares-to-initiate-pivotal-phase-3-studies-bxcl501-following-positive\" target=\"_blank\">announcement </a>that the FDA has signed off on the key design elements of its late-stage SERENITY program evaluating BXCL501, a sublingual thin film of a sedative called dexmedetomidine, for the acute treatment of agitation in patients with schizophrenia and bipolar disorder.</li><li>Two Phase 3 trials should launch this month with topline results available in mid-2020.</li><li>Dexmedetomidine is the active ingredient in Pfizer's <a href=\"https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021038s021lbl.pdf\" target=\"_blank\">Precedex</a>, approved in the U.S. in 1999 as a short-term sedative and analgesic in critically ill or injured patients on mechanical ventilation in an ICU setting.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523384\" data-linked=\"BioXcel up 5% on advancement of BXCL501\" data-tweet=\"$BTAI - BioXcel up 5% on advancement of BXCL501 https://seekingalpha.com/news/3523384-bioxcel-up-5-on-advancement-of-bxcl501?source=tweet\" data-url=\"https://seekingalpha.com/news/3523384-bioxcel-up-5-on-advancement-of-bxcl501\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:55 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523381\" data-ts=\"1575390756\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LXRX\" target=\"_blank\">LXRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523381-lexicon-pharma-up-6-on-advancement-of-biliary-cancer-candidate\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lexicon Pharma up 6% on advancement of biliary cancer candidate</a></h4><ul><li>Lexicon Pharmaceuticals (<a href='https://seekingalpha.com/symbol/LXRX' title='Lexicon Pharmaceuticals, Inc.'>LXRX</a> <font color=\"green\">+5.7%</font>) is up, albeit on below-average volume, on the heels of a <a href=\"https://seekingalpha.com/pr/17715938-lexicon-pharmaceuticals-completes-safety-review-of-initial-safety-run-in-cohort-of-tele-abc\" target=\"_blank\">safety review</a> of the initial run-in cohort in a Phase 2 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT03790111?lead=lexicon&amp;phase=1&amp;draw=2&amp;rank=1\" target=\"_blank\">TELE-ABC</a>, evaluating telotristat ethyl, combined with first-line chemo, for the treatment of patients with advanced biliary tract cancer.</li><li>The company says data on first six participants who completed at least one 21-day treatment cycle, combined with cisplatin and gemcitabine, support continued enrollment with no adjustments in the dosing regimen.</li><li>Six-month progression-free survival data on the first 20 patients should be available in 2020.</li><li>Telotristat ethyl, an oral typtophan hydroxylase inhibitor branded as <a href=\"https://www.xermelo.com/\" target=\"_blank\">Xermelo</a>, was approved in the U.S. in February 2017 for carcinoid syndrome diarrhea in patients with metastatic neuroendocrine tumors (combined with somatostatin analog therapy).</li><li>Related ticker: Ipsen S.A. (<a href='https://seekingalpha.com/symbol/IPSEY' title='Ipsen S.A.'>OTCPK:IPSEY</a>) (owns commercialization and licensing rights ex-U.S. and Japan).</li></ul><div class=\"tiny-share-widget\" data-id=\"3523381\" data-linked=\"Lexicon Pharma up 6% on advancement of biliary cancer candidate\" data-tweet=\"$LXRX $IPSEY $IPSEF - Lexicon Pharma up 6% on advancement of biliary cancer candidate https://seekingalpha.com/news/3523381-lexicon-pharma-up-6-on-advancement-of-biliary-cancer-candidate?source=tweet\" data-url=\"https://seekingalpha.com/news/3523381-lexicon-pharma-up-6-on-advancement-of-biliary-cancer-candidate\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:32 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523378\" data-ts=\"1575389670\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMMU\" target=\"_blank\">IMMU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523378-immunomedics-refiles-u-s-application-for-tnbc-candidate-shares-up-1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Immunomedics refiles U.S. application for TNBC candidate; shares up 1%</a></h4><ul><li>Immunomedics (<a href='https://seekingalpha.com/symbol/IMMU' title='Immunomedics, Inc.'>IMMU</a> <font color=\"green\">+1.3%</font>) bucks the broad market selloff, albeit on below-average volume, with its <a href=\"https://seekingalpha.com/pr/17716117-immunomedics-resubmits-biologics-license-application-to-fda-for-sacituzumab-govitecan\" target=\"_blank\">resubmission </a>of a U.S. marketing application seeking accelerated approval to use antibody-drug conjugate sacituzumab govitecan to treat patients with metastatic triple-negative breast cancer &#40;TNBC&#41; who have received at least two prior lines of therapy.</li><li>The company <a href=\"https://seekingalpha.com/news/3424153-immunomedics-receives-crl-for-sacituzumab-govitecan\" target=\"_blank\">received a CRL</a> in January in response to its initial filing.</li><li><strong>Update</strong>: In a telephone interview, Executive Chairman Behzad Aghazadeh stated that the company expects the FDA to categorize the resubmission as type 2 which allows up to six months to complete the review.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523378\" data-linked=\"Immunomedics refiles U.S. application for TNBC candidate; shares up 1%\" data-tweet=\"$IMMU - Immunomedics refiles U.S. application for TNBC candidate; shares up 1% https://seekingalpha.com/news/3523378-immunomedics-refiles-u-s-application-for-tnbc-candidate-shares-up-1?source=tweet\" data-url=\"https://seekingalpha.com/news/3523378-immunomedics-refiles-u-s-application-for-tnbc-candidate-shares-up-1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523376\" data-ts=\"1575389187\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523376-uniqure-and-viewray-among-healthcare-gainers-cara-therapeutics-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">UniQure and ViewRay among healthcare gainers; Cara Therapeutics among losers</a></h4><ul><li><b>Gainers: </b>Audentes Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/BOLD' title='Audentes Therapeutics, Inc.'>BOLD</a>) <font color=\"green\">+105%</font>. DarioHealth (NASDAQ:<a href='https://seekingalpha.com/symbol/DRIO' title='DarioHealth Corp.'>DRIO</a>) <font color=\"green\">+52%</font>. ViewRay (NASDAQ:<a href='https://seekingalpha.com/symbol/VRAY' title='ViewRay, Inc.'>VRAY</a>) <font color=\"green\">+32%</font>. Atreca (NASDAQ:<a href='https://seekingalpha.com/symbol/BCEL' title='Atreca, Inc.'>BCEL</a>) <font color=\"green\">+18%</font>. uniQure (NASDAQ:<a href='https://seekingalpha.com/symbol/QURE' title='uniQure N.V.'>QURE</a>) <font color=\"green\">+15%</font>.</li><li><b>Losers: </b>ASLAN Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ASLN' title='ASLAN Pharmaceuticals Limited'>ASLN</a>) <font color=\"red\">-47%</font>. Protagonist Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/PTGX' title='Protagonist Therapeutics, Inc.'>PTGX</a>) <font color=\"red\">-33%</font>. Aldeyra Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ALDX' title='Aldeyra Therapeutics, Inc.'>ALDX</a>) <font color=\"red\">-28%</font>. Cara Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/CARA' title='Cara Therapeutics, Inc.'>CARA</a>) <font color=\"red\">-27%</font>. Eyenovia (NASDAQ:<a href='https://seekingalpha.com/symbol/EYEN' title='Eyenovia, Inc.'>EYEN</a>) <font color=\"red\">-11%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523376\" data-linked=\"UniQure and ViewRay among healthcare gainers; Cara Therapeutics among losers\" data-tweet=\"$BOLD $DRIO $VRAY - UniQure and ViewRay among healthcare gainers; Cara Therapeutics among losers https://seekingalpha.com/news/3523376-uniqure-and-viewray-among-healthcare-gainers-cara-therapeutics-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3523376-uniqure-and-viewray-among-healthcare-gainers-cara-therapeutics-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:06 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523375\" data-ts=\"1575389177\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EGY\" target=\"_blank\">EGY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523375-vaalcos-etame-development-well-starts-higher-expected-output-rate\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vaalco&#39;s Etame development well starts at higher than expected output rate</a></h4><ul><li>Vaalco Energy (<a href='https://seekingalpha.com/symbol/EGY' title='VAALCO Energy, Inc.'>EGY</a> <font color=\"green\">+6.9%</font>) says it completed drilling a development well at the Etame field offshore Gabon and has placed the well on production at  a <a href=\"https://seekingalpha.com/pr/17715700-vaalco-announces-etame-9h-development-well-successfully-completed-and-placed-on-production\" target=\"_blank\">higher than anticipated rate</a>.</li><li>EGY says it brought the Etame 9H development well onto production at a stabilized flow  rate of 5,500 gross bbl/day of oil, 1,500 net to the company.</li><li>EGY says production was higher than the pre-drill estimate of 2,500-3,500 gross bbl/day due to high reservoir quality and increases its forecast 2019 net exit production rate to 4,500-4,700  bbl/day from its prior estimate of 3,800-4,100 bbl/day.</li><li>The company says it has started drilling another development well  on the Etame field, with production expected to come online in late January.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523375\" data-linked=\"Vaalco&#39;s Etame development well starts at higher than expected output rate\" data-tweet=\"$EGY - Vaalco&#39;s Etame development well starts at higher than expected output rate https://seekingalpha.com/news/3523375-vaalcos-etame-development-well-starts-higher-expected-output-rate?source=tweet\" data-url=\"https://seekingalpha.com/news/3523375-vaalcos-etame-development-well-starts-higher-expected-output-rate\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523374\" data-ts=\"1575389129\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XRX\" target=\"_blank\">XRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523374-xeroxminus-2-on-downside-fy-eps-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Xerox -2% on downside FY EPS outlook</a></h4><ul><li>Xerox (NYSE:<a href='https://seekingalpha.com/symbol/XRX' title='Xerox Holdings Corporation'>XRX</a>) <a href=\"https://seekingalpha.com/filing/4722192\" target=\"_blank\">updates</a> its FY guidance to reflect the <a href=\"https://seekingalpha.com/news/3514169-xerox-selling-out-of-57-year-old-jv-fujifilm\" target=\"_blank\">restructuring</a> of its Fujifilm relationship.</li><li>XRX sees FY EPS of $3.30-3.40, below the $4.05 consensus.</li><li>Xerox shares are <font color=\"red\">down 2%</font> to $37.69.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523374\" data-linked=\"Xerox -2% on downside FY EPS outlook\" data-tweet=\"$XRX - Xerox -2% on downside FY EPS outlook https://seekingalpha.com/news/3523374-xeroxminus-2-on-downside-fy-eps-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3523374-xeroxminus-2-on-downside-fy-eps-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523364\" data-ts=\"1575388825\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BICX\" target=\"_blank\">BICX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523364-biocorrx-up-8-on-encouraging-data-on-opioid-overdose-candidate\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BioCorRx up 8% on encouraging data on opioid overdose candidate</a></h4><ul><li>Ultra-thinly traded nano cap BioCorRx (<a href='https://seekingalpha.com/symbol/BICX' title='BioCorRx Inc.'>OTCQB:BICX</a> <font color=\"green\">+7.7%</font>) is up, albeit on only 700 shares, in reaction to encouraging <a href=\"https://seekingalpha.com/pr/17716305-biocorrx-s-subsidiary-biocorrx-pharmaceuticals-provides-update-on-potential-overdose-reversal\" target=\"_blank\">preclinical data</a> on VDM-001, its candidate for the reversal of opioid overdose that it says is an alternative to naloxone.</li><li>The company cites early preclinical data that supports the potential ability of VDM-001 to completely prevent the effects of fentanyl, an opioid that is up to 100x as potent as morphine that is commonly found in illicitly manufactured oxycodone and responsible for many overdose deaths.</li><li>The candidate, being developed by subsidiary BioCorRx Pharmaceuticals and VDM Biochemicals, is a 100% synthetic antagonist that BioCorRx says should be easier and quicker to make than naloxone (whether an injectable or nasal spray formulation is not provided).</li><li>Naloxone-related tickers: Aurobindo Pharma (<a href='https://seekingalpha.com/symbol/ARBQY' title='Aurobindo Pharma Ltd. ADR'>OTC:ARBQY</a>), Adamis Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ADMP' title='Adamis Pharmaceuticals Corporation'>ADMP</a> <font color=\"red\">-3.2%</font>), Emergent BioSolutions (<a href='https://seekingalpha.com/symbol/EBS' title='Emergent BioSolutions Inc.'>EBS</a> <font color=\"red\">-0.1%</font>), Opiant Pharmaceuticals (<a href='https://seekingalpha.com/symbol/OPNT' title='Opiant Pharmaceuticals, Inc.'>OPNT</a> <font color=\"red\">-2%</font>), Amphastar Pharmaceuticals (<a href='https://seekingalpha.com/symbol/AMPH' title='Amphastar Pharmaceuticals, Inc.'>AMPH</a> <font color=\"green\">+0.4%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3523364\" data-linked=\"BioCorRx up 8% on encouraging data on opioid overdose candidate\" data-tweet=\"$BICX $ARBQY $ADMP - BioCorRx up 8% on encouraging data on opioid overdose candidate https://seekingalpha.com/news/3523364-biocorrx-up-8-on-encouraging-data-on-opioid-overdose-candidate?source=tweet\" data-url=\"https://seekingalpha.com/news/3523364-biocorrx-up-8-on-encouraging-data-on-opioid-overdose-candidate\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523370\" data-ts=\"1575388293\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523370-universal-technical-instituteplus-2_7-post-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Universal Technical Institute +2.7% post Q4 results</a></h4><ul><li>Universal Technical Institute (<a href='https://seekingalpha.com/symbol/UTI' title='Universal Technical Institute, Inc.'>UTI</a> <font color=\"green\">+2.7%</font>) reports <a href=\"https://seekingalpha.com/pr/17715388-universal-technical-institute-reports-fiscal-year-2019-fourth-quarter-and-year-end-results\" target=\"_blank\">Q4</a> revenue growth of 9.2% Y/Y to $87.67M.</li><li>Operating expenses were $82.2M (-10% Y/Y), the decrease was attributable to lower contract and professional services expenses, total compensation and related costs and advertising.</li><li>Adj. operating income was $5.8M compared to loss of $8.6M Y/Y.</li><li>Adj. EBITDA gain was $10.4M compared to loss $4.1M Y/Y.</li><li>Student Metrics:<b> </b>Total starts were 6,437 (+6.9% Y/Y); Average undergraduate full-time student enrolment 10,933 (+4.2% Y/Y); End of period undergraduate full-time student enrolment 12,363 (+3.6% Y/Y).</li><li>Generated $21.75M in CFO and adj. FCF was $20.71M.</li><li><b>2020 Outlook:</b> New student starts growth up 2.5%-4.5%; Average student population growth up 1-2%; Revenue $338-345M; Operating expenses $330-335M; Operating loss $8-13M; adj. operating loss $13-18M; adj. EBITDA $26.5-31.5M; adj. FCF of $23.5-28.5M &amp; Capex $8-9.5M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3523091-universal-technical-institute-eps-beats-0_04-beats-on-revenue\" target=\"_blank\">Universal Technical Institute EPS beats by $0.04, beats on revenue</a> (Dec. 02 2019)</li></ul><div class=\"tiny-share-widget\" data-id=\"3523370\" data-linked=\"Universal Technical Institute +2.7% post Q4 results\" data-tweet=\"$UTI - Universal Technical Institute +2.7% post Q4 results https://seekingalpha.com/news/3523370-universal-technical-instituteplus-2_7-post-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3523370-universal-technical-instituteplus-2_7-post-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523372\" data-ts=\"1575388263\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TLT\" target=\"_blank\">TLT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523372-stocks-sliding-money-moves-fixed-income-and-gold\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">With stocks sliding, money moves into fixed income and gold</a></h4><ul><li>Trade fears have the major averages down for a 2nd consecutive day, with the S&amp;P 500, Nasdaq, and DJIA all <font color=\"red\">lower by more than 1%</font>.</li><li>That's helping a couple of safe havens, notably long-dated U.S. government paper and gold. The 10-year Treasury yield is down a full 10 basis points to 1.72%, and the yellow metal is <font color=\"green\">higher by 1%</font> to $1,484. <a href='https://seekingalpha.com/symbol/TLT' title='iShares 20+ Year Treasury Bond ETF'>TLT</a> <font color=\"green\">+2%</font>, <a href='https://seekingalpha.com/symbol/TBT' title='ProShares UltraShort 20+ Year Treasury ETF'>TBT</a> <font color=\"red\">-3.7%</font>, <a href='https://seekingalpha.com/symbol/GLD' title='SPDR Gold Trust ETF'>GLD</a> <font color=\"green\">+1.1%</font></li><li>Alongside, sectors like the REITs (<a href='https://seekingalpha.com/symbol/IYR' title='iShares U.S. Real Estate ETF'>IYR</a> <font color=\"green\">+0.6%</font>) and the gold miners (<a href='https://seekingalpha.com/symbol/GDX' title='VanEck Vectors Gold Miners ETF'>GDX</a> <font color=\"green\">+1.8%</font>) are nicely in the green.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523372\" data-linked=\"With stocks sliding, money moves into fixed income and gold\" data-tweet=\"$TLT $TBT $GLD - With stocks sliding, money moves into fixed income and gold https://seekingalpha.com/news/3523372-stocks-sliding-money-moves-fixed-income-and-gold?source=tweet\" data-url=\"https://seekingalpha.com/news/3523372-stocks-sliding-money-moves-fixed-income-and-gold\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523369\" data-ts=\"1575388165\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523369-judge-approves-3_4b-inmarsat-buyout\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Judge approves $3.4B Inmarsat buyout</a></h4><ul>   <li>A judge has approved the $3.4B private-equity buyout of Inmarsat (<a href=\"http://seekingalpha.com/symbol/IMASY\" target=\"_blank\">IMASY</a> <font color=\"green\">+3.7%</font>) after hedge funds withdrew their opposition to the deal.</li>    <li>That back-off comes hours before a court hearing on the deal.</li>    <li>Oaktree, Kite Lake and Rubric had said the transaction risked undervaluing the satellite company.</li>    <li>But now the buyout by a consortium including Apax Partners and Warburg Pincus has court approval.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3523369\" data-linked=\"Judge approves $3.4B Inmarsat buyout\" data-tweet=\"$IMASY $IMASF - Judge approves $3.4B Inmarsat buyout https://seekingalpha.com/news/3523369-judge-approves-3_4b-inmarsat-buyout?source=tweet\" data-url=\"https://seekingalpha.com/news/3523369-judge-approves-3_4b-inmarsat-buyout\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:49 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523363\" data-ts=\"1575387428\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523363-consumer-discretionary-stocks-tumble\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer discretionary stocks tumble</a></h4><ul> <li>Consumer discretionary stocks are underperforming the broad market today as trade news wipes away some of the good cheer from a strong Black Friday to Cyber Monday sales performance. The damage is being tied to a comment by President Trump that a trade deal could wait until after the 2020 election.</li> <li>Notable decliners include Party City (<a href='https://seekingalpha.com/symbol/PRTY' title='Party City Holdco Inc.'>PRTY</a> <font color=\"red\">-3.7%</font>), Alibaba (<a href='https://seekingalpha.com/symbol/BABA' title='Alibaba Group Holding Limited'>BABA</a> <font color=\"red\">-1.9%</font>), Etsy (<a href='https://seekingalpha.com/symbol/ETSY' title='Etsy, Inc.'>ETSY</a> <font color=\"red\">-2%</font>), Farfetch (<a href='https://seekingalpha.com/symbol/FTCH' title='Farfetch Limited'>FTCH</a> <font color=\"red\">-2%</font>), Five Below (<a href='https://seekingalpha.com/symbol/FIVE' title='Five Below, Inc.'>FIVE</a> <font color=\"red\">-3.5%</font>), Macy's (<a href='https://seekingalpha.com/symbol/M' title='Macy&#39;s, Inc.'>M</a> <font color=\"red\">-2.5%</font>), Tapestry (<a href='https://seekingalpha.com/symbol/TPR' title='Tapestry, Inc.'>TPR</a> <font color=\"red\">-3.6%</font>), Bed Bath &amp; Beyond (<a href='https://seekingalpha.com/symbol/BBBY' title='Bed Bath & Beyond Inc.'>BBBY</a> <font color=\"red\">-3.2%</font>), Capri (<a href='https://seekingalpha.com/symbol/CPRI' title='Capri Holdings Limited'>CPRI</a> <font color=\"red\">-2.6%</font>), Best Buy (<a href='https://seekingalpha.com/symbol/BBY' title='Best Buy Co., Inc.'>BBY</a> <font color=\"red\">-2.2%</font>), L Brands (<a href='https://seekingalpha.com/symbol/LB' title='L Brands, Inc.'>LB</a> <font color=\"red\">-2.9%</font>), Urban Outfitters (<a href='https://seekingalpha.com/symbol/URBN' title='Urban Outfitters, Inc.'>URBN</a> <font color=\"red\">-2.9%</font>), Nordstrom (<a href='https://seekingalpha.com/symbol/JWN' title='Nordstrom, Inc.'>JWN</a> <font color=\"red\">-2.7%</font>), Gap (<a href='https://seekingalpha.com/symbol/GPS' title='The Gap, Inc.'>GPS</a> <font color=\"red\">-2.2%</font>), Ross Store (<a href='https://seekingalpha.com/symbol/ROST' title='Ross Stores, Inc.'>ROST</a> <font color=\"red\">-1.5%</font>), Boot Barn (<a href='https://seekingalpha.com/symbol/BOOT' title='Boot Barn Holdings, Inc.'>BOOT</a> <font color=\"red\">-3.2%</font>), Ollie's Bargain Outlet Stores (<a href='https://seekingalpha.com/symbol/OLLI' title='Ollie&#39;s Bargain Outlet Holdings, Inc.'>OLLI</a> <font color=\"red\">-3.4%</font>), Lumber Liquidators (<a href='https://seekingalpha.com/symbol/LL' title='Lumber Liquidators Holdings, Inc.'>LL</a> <font color=\"red\">-4.5%</font>), GameStop (<a href='https://seekingalpha.com/symbol/GME' title='GameStop Corp.'>GME</a> <font color=\"red\">-2.8%</font>), Home Depot (<a href='https://seekingalpha.com/symbol/HD' title='The Home Depot, Inc.'>HD</a> <font color=\"red\">-1.7%</font>), and Big Lots (<a href='https://seekingalpha.com/symbol/BIG' title='Big Lots, Inc.'>BIG</a> <font color=\"red\">-1.3%</font>).</li> <li>ETFs: <a href='https://seekingalpha.com/symbol/XLY' title='Consumer Discretionary Select Sector SPDR ETF'>XLY</a>, <a href='https://seekingalpha.com/symbol/XRT' title='SPDR S&P Retail ETF'>XRT</a>, <a href='https://seekingalpha.com/symbol/VCR' title='Vanguard Consumer Discretionary ETF'>VCR</a>, <a href='https://seekingalpha.com/symbol/FDIS' title='Fidelity Covington Trust - Fidelity MSCI Consumer Discretionary Index ETF'>FDIS</a>, <a href='https://seekingalpha.com/symbol/RTH' title='VanEck Vectors Retail ETF'>RTH</a>, <a href='https://seekingalpha.com/symbol/RETL' title='Direxion Daily Retail Bull 3x Shares ETF'>RETL</a>, <a href='https://seekingalpha.com/symbol/EMTY' title='ProShares Trust - ProShares Decline of the Retail Store ETF'>EMTY</a>, <a href='https://seekingalpha.com/symbol/FXD' title='First Trust Consumer Discretionary AlphaDEX ETF'>FXD</a>, <a href='https://seekingalpha.com/symbol/RCD' title='Invesco Exchange-Traded Fund Trust - Invesco S&P 500 Equal Weight Consumer Discretionary ETF'>RCD</a>, <a href='https://seekingalpha.com/symbol/WANT' title='Direxion Daily Consumer Discretionary Bull 3X Shares'>WANT</a>, <a href='https://seekingalpha.com/symbol/PMR' title='Invesco Exchange-Traded Fund Trust - Invesco Dynamic Retail ETF'>PMR</a>, <a href='https://seekingalpha.com/symbol/PSCD' title='Invesco Exchange-Traded Fund Trust II - Invesco S&P SmallCap Consumer Discretionary ETF'>PSCD</a>, <a href='https://seekingalpha.com/symbol/PASS' title='Direxion Daily Consumer Discretionary Bear 3X Shares'>PASS</a>, <a href='https://seekingalpha.com/symbol/FTXD' title='First Trust Exchange-Traded Fund VI - First Trust Nasdaq Retail ETF'>FTXD</a>, <a href='https://seekingalpha.com/symbol/JHMC' title='John Hancock Exchange-Traded Fund Trust - John Hancock Multifactor Consumer Discretionary ETF'>JHMC</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3523363\" data-linked=\"Consumer discretionary stocks tumble\" data-tweet=\"$PRTY $BABA $ETSY - Consumer discretionary stocks tumble https://seekingalpha.com/news/3523363-consumer-discretionary-stocks-tumble?source=tweet\" data-url=\"https://seekingalpha.com/news/3523363-consumer-discretionary-stocks-tumble\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>87&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523361\" data-ts=\"1575387329\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DCI\" target=\"_blank\">DCI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523361-donaldson-down-5-post-q1-results-miss-reaffirms-fy20-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Donaldson down 5% post Q1 results miss; reaffirms FY20 guidance</a></h4><div><ul><li>Donaldson (<a href='https://seekingalpha.com/symbol/DCI' title='Donaldson Company, Inc.'>DCI</a> <font color=\"red\">-5.2%</font>) reported Q1 net sales decline of 4.1% Y/Y to $672.7M, and decline of 2.7% Y/Y on constant currency basis.</li><li>Engine Products segment sales were $459.2M (-4.5% Y/Y) and Industrial Products segment sales were $213.5M (-3.2% Y/Y).</li><li>Sales percent change by geography: US/Canada -6% Y/Y; EMEA -0.8% Y/Y; APAC -9.4% Y/Y and LATAM +9.1% Y/Y.</li><li>Q1 Gross margin <font color=\"green\">expanded by 40 bps</font> to 34.4%; and operating margin <font color=\"red\">declined by 90 bps</font> to 13.2%.</li><li>Q1 EBITDA was $112.5M (-6.2% Y/Y) and margin <font color=\"red\">declined by 37 bps</font> to 16.7%.</li><li>Net cash provided by operating activities was $86.1M, compared to $63.3M a year ago.</li><li><strong>FY20 Outlook, reaffirmed:</strong> GAAP EPS $2.21 to $2.37; Adj. EPS $2.05 to $2.21; Sales decline between 2% to 4%; operating margin 13.9% to 14.5%; Capex $110M to $130M; and effective tax rate 25% to 27%.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3523264-donaldson-eps-misses-0_02-misses-on-revenue\" target=\"_blank\">Donaldson EPS misses by $0.02, misses on revenue</a> (Dec. 3)</li></ul></div><div class=\"tiny-share-widget\" data-id=\"3523361\" data-linked=\"Donaldson down 5% post Q1 results miss; reaffirms FY20 guidance\" data-tweet=\"$DCI - Donaldson down 5% post Q1 results miss; reaffirms FY20 guidance https://seekingalpha.com/news/3523361-donaldson-down-5-post-q1-results-miss-reaffirms-fy20-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3523361-donaldson-down-5-post-q1-results-miss-reaffirms-fy20-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:35 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523360\" data-ts=\"1575387273\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DRIO\" target=\"_blank\">DRIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523360-dariohealth-up-62-on-walmart-launch-of-diabetes-platform\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DarioHealth up 62% on Walmart launch of diabetes platform</a></h4><ul><li>Thinly traded nano cap DarioHealth (<a href='https://seekingalpha.com/symbol/DRIO' title='DarioHealth Corp.'>DRIO</a> <font color=\"green\">+61.7%</font>) is up on a healthy 42x surge in volume in reaction to the <a href=\"https://seekingalpha.com/pr/17716260-walmart-starts-distributing-dariohealth-digital-diabetes-management-system\" target=\"_blank\">launch </a>of its <a href=\"https://mydario.com/?_ga=2.57193196.711800220.1575387138-1911126671.1575387138\" target=\"_blank\">digital diabetes platform</a> on Walmart.com.</li><li>The company boasts that the app is among the most downloaded and highest rated on the Apple store.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523360\" data-linked=\"DarioHealth up 62% on Walmart launch of diabetes platform\" data-tweet=\"$DRIO - DarioHealth up 62% on Walmart launch of diabetes platform https://seekingalpha.com/news/3523360-dariohealth-up-62-on-walmart-launch-of-diabetes-platform?source=tweet\" data-url=\"https://seekingalpha.com/news/3523360-dariohealth-up-62-on-walmart-launch-of-diabetes-platform\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523356\" data-ts=\"1575386534\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTGX\" target=\"_blank\">PTGX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523356-protagonist-down-26-on-interim-ptgminus-300-data-in-beta-thalassemia\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Protagonist down 26% on interim PTG-300 data in beta thalassemia</a></h4><ul><li>Investors appear disappointed that Protagonist Therapeutics (<a href='https://seekingalpha.com/symbol/PTGX' title='Protagonist Therapeutics, Inc.'>PTGX</a> <font color=\"red\">-25.5%</font>) did not <a href=\"https://seekingalpha.com/pr/17715918-protagonist-therapeutics-announces-preliminary-phase-2-results-hepcidin-mimetic-ptgminus-300\" target=\"_blank\">announce </a>more definitive results from a Phase 2 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT03802201?lead=protagonist&amp;phase=1&amp;draw=2&amp;rank=3\" target=\"_blank\">TRANSCEND</a>, evaluating PTG-300 in patients with transfusion-dependent <a href=\"https://ghr.nlm.nih.gov/condition/beta-thalassemia\" target=\"_blank\">beta thalassemia</a>, a blood disorder characterized by chronic anemia and iron overload.</li><li>The company says preliminary data showed dose-related drug exposure and reductions in serum iron and transferrin saturation levels from baseline for the 40 mg and 80 mg weekly doses. There were some clinical responders as measured by reductions in transfusion burden, but \"continued evaluation at higher doses will be required\" to definitively assess the rate and durability of the effects. Additional data, including results from longer follow-up periods and additional dosing regimens, should be available in 2020.</li><li>On the safety front, the most frequent treatment-related adverse event was transient erythema (reddening of the skin) (12%, n=4/33).</li><li>PTG-300 is an injectable hepcidin mimetic peptide. Hepcidin is a peptide hormone that plays a key role in regulating iron absorption, recycling and utilization. It has Orphan Drug and Fast Track status in the U.S. for the indication.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523356\" data-linked=\"Protagonist down 26% on interim PTG-300 data in beta thalassemia\" data-tweet=\"$PTGX - Protagonist down 26% on interim PTG-300 data in beta thalassemia https://seekingalpha.com/news/3523356-protagonist-down-26-on-interim-ptgminus-300-data-in-beta-thalassemia?source=tweet\" data-url=\"https://seekingalpha.com/news/3523356-protagonist-down-26-on-interim-ptgminus-300-data-in-beta-thalassemia\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523351\" data-ts=\"1575386017\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MESA\" target=\"_blank\">MESA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523351-mesa-air-group-adds-new-aircraft-extends-contract-united-airlines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mesa Air Group adds new aircraft, extends contract with United Airlines</a></h4><ul><li>Mesa Air Group (<a href='https://seekingalpha.com/symbol/MESA' title='Mesa Air Group, Inc.'>MESA</a> <font color='green'>+3.1%</font>) will add 20 new Embraer E175 LL aircraft to its United Express fleet. Embraer E175 LL features 70 seats in a three-class configuration.</li><li>The aircraft will be owned and financed by Mesa and be covered under a 12-year capacity purchase agreement.</li><li>Deliveries are scheduled to begin May 2020 and expected to be completed by the end of 2020.</li><li>The parties are also extending the contract for 42 E175s for an additional 5 years and Mesa\u2019s 20 Bombardier CRJ-700 aircraft will be leased to another United Express carrier for a term of 7 years.</li><li><a href=\"https://seekingalpha.com/pr/17715949-mesa-air-group-adds-new-aircraft-extends-contract-united-airlines\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3523351\" data-linked=\"Mesa Air Group adds new aircraft, extends contract with United Airlines\" data-tweet=\"$MESA - Mesa Air Group adds new aircraft, extends contract with United Airlines https://seekingalpha.com/news/3523351-mesa-air-group-adds-new-aircraft-extends-contract-united-airlines?source=tweet\" data-url=\"https://seekingalpha.com/news/3523351-mesa-air-group-adds-new-aircraft-extends-contract-united-airlines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523349\" data-ts=\"1575385788\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DAL\" target=\"_blank\">DAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523349-delta-air-linesminus-3-after-load-factor-slides\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Delta Air Lines -3% after load factor slides</a></h4><ul> <li>Delta Air Lines (<a href='https://seekingalpha.com/symbol/DAL' title='Delta Air Lines, Inc.'>DAL</a> <font color='red'>-3.3%</font>) <a href=\"https://seekingalpha.com/pr/17716559-delta-reports-operating-performance-for-november-2019\" target=\"_blank\">reports</a> traffic was up 1.8% in November to fall well-short of the 4.0% increase in capacity.</li> <li>Domestic traffic was 1.5% higher against a 4.9% gain in capacity.</li> <li>Delta's domestic load factor was down 280 bps during the month to 84.2%, while total load factor was off 180 bps to 84.0%.</li><li>The drop in Delta is larger than the decline of the broad market.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3523349\" data-linked=\"Delta Air Lines -3% after load factor slides\" data-tweet=\"$DAL - Delta Air Lines -3% after load factor slides https://seekingalpha.com/news/3523349-delta-air-linesminus-3-after-load-factor-slides?source=tweet\" data-url=\"https://seekingalpha.com/news/3523349-delta-air-linesminus-3-after-load-factor-slides\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>41&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523346\" data-ts=\"1575385479\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MET\" target=\"_blank\">MET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523346-metlife-talks-to-sell-european-assets-to-generali-hit-snag-reuters\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MetLife talks to sell European assets to Generali hit snag - Reuters</a></h4><ul><li>Italian insurer Assicurazioni Generali has held talks with MetLife (<a href='https://seekingalpha.com/symbol/MET' title='MetLife, Inc.'>MET</a> <font color='red'>-2.5%</font>) to buy most of its European assets but <a href=\"https://www.reuters.com/article/metlifeeurope-ma-generali/generalis-metlife-gambit-hits-price-snag-sources-idUSL8N28C4ZY\" target=\"_blank\">discussions have  stalled</a> due to differences over price, Reuters reports.</li><li>Europe's third biggest insurer first approached MET earlier this  year, offering to take on most of its underperforming European business, but talks dragged on for more than six months and were slowed by  management changes at MET, according to the report.</li><li>Generali (<a href='https://seekingalpha.com/symbol/ARZGF' title='Assicurazioni Generali S.p.A.'>OTCPK:ARZGF</a>) is said to want to boost its presence in certain European countries to  drive earnings after pulling back from non-core markets including  Belgium and the Netherlands last year.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523346\" data-linked=\"MetLife talks to sell European assets to Generali hit snag - Reuters\" data-tweet=\"$MET $ARZGF $ARZGY - MetLife talks to sell European assets to Generali hit snag - Reuters https://seekingalpha.com/news/3523346-metlife-talks-to-sell-european-assets-to-generali-hit-snag-reuters?source=tweet\" data-url=\"https://seekingalpha.com/news/3523346-metlife-talks-to-sell-european-assets-to-generali-hit-snag-reuters\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523344\" data-ts=\"1575385366\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TM\" target=\"_blank\">TM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523344-toyota-motor-u-s-november-sales-rose-9_2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Toyota Motor U.S. November sales rose 9.2%</a></h4><ul><li>Toyota (<a href='https://seekingalpha.com/symbol/TM' title='Toyota Motor Corporation'>TM</a> <font color='green'>+0.1%</font>) unit sales <a href=\"https://seekingalpha.com/pr/17716660-toyota-motor-north-america-reports-november-2019-sales\" sasource=\"qp_sum_news_5\" target=\"_blank\">+9.2%</a> to 207,857 units in November.</li><li>Hybrid sales grew 65.4%; Toyota division hybrid sales increased 68.4% and +51.4% for Lexus division.</li><li>YTD unit sales down 1.4% to 2,175,976 units.</li><li>Toyota division sales advanced 8.4% to 177,764 units.</li><li>Lexus division sales increased 13.8% to 30,093 units.</li><li>Total YARIS sales decreased 36.6% to 910 units.</li><li>Total Corolla sales expanded 17.3% to 24,752 units.</li><li>Camry sales rose 4.3% to 25,611 units.</li><li>Prius sales +11.9% to 6,723 units.</li><li>On the SUV front, RAV4 sales +26.4%, Highlander sales -0.9% and Land Cruiser +2.8%.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523344\" data-linked=\"Toyota Motor U.S. November sales rose 9.2%\" data-tweet=\"$TM - Toyota Motor U.S. November sales rose 9.2% https://seekingalpha.com/news/3523344-toyota-motor-u-s-november-sales-rose-9_2?source=tweet\" data-url=\"https://seekingalpha.com/news/3523344-toyota-motor-u-s-november-sales-rose-9_2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523343\" data-ts=\"1575385228\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QTT\" target=\"_blank\">QTT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523343-qutoutiaominus-3_4-after-loss-numbers-disappoint\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Qutoutiao -3.4% after loss numbers disappoint</a></h4><ul>   <li>Qutoutiao (NASDAQ:<a href='https://seekingalpha.com/symbol/QTT' title='Qutoutiao Inc.'>QTT</a>) is <font color=\"red\">off 3.4%</font> after its <a href=\"https://seekingalpha.com/news/3523246-qutoutiao-eps-misses-0_14-beats-on-revenue\" target=\"_blank\">Q3 losses</a> fell short of expectations despite largely meeting revenue consensus.</li>    <li>Revenues rose 44% to 1.41B yuan (about $196.8M). Of that, core advertising and marketing revenues rose 54.1% to 1.38B yuan.</li>    <li>Gross profit rose 10.6% to 910.8M yuan (about $127.4M); gross margin fell to 64.7% from 84.3%.</li>    <li>And net loss narrowed on a GAAP basis to 888.4M yuan from a year-ago loss of 1.03B yuan; non-GAAP net loss was 833.1M vs. a year-ago loss of 298.4M yuan.</li>    <li>In user metrics, combined average monthly active users more than doubled year-over-year to 133.9M, and combined average daily active users rose 97.7% to 42.1M.</li>    <li>Average daily time spent per DAU rose to 61.3 minutes from a year-ago 55.9 minutes.</li>    <li>It's guiding to Q4 net revenues of 1.6B-1.62B yuan.</li>    <li><a href=\"https://seekingalpha.com/pr/17715810-qutoutiao-inc-reports-third-quarter-2019-unaudited-financial-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3523343\" data-linked=\"Qutoutiao -3.4% after loss numbers disappoint\" data-tweet=\"$QTT - Qutoutiao -3.4% after loss numbers disappoint https://seekingalpha.com/news/3523343-qutoutiaominus-3_4-after-loss-numbers-disappoint?source=tweet\" data-url=\"https://seekingalpha.com/news/3523343-qutoutiaominus-3_4-after-loss-numbers-disappoint\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523341\" data-ts=\"1575384974\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBL\" target=\"_blank\">CBL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523341-retail-landlords-mull-cbls-dividend-suspension\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Retail landlords mull CBL&#39;s dividend suspension</a></h4><ul><li>CBL &amp; Associates (NYSE:<a href='https://seekingalpha.com/symbol/CBL' title='CBL & Associates Properties, Inc'>CBL</a>) is <font color=\"red\">down more than 30%</font> after last night <a href=\"https://seekingalpha.com/news/3523216-cbl-suspends-all-dividends-expects-drop-in-2020-income\" target=\"_blank\">announcing suspensions for all</a> common and preferred dividends. \"Preserving free cash flow is a paramount objective for CBL at this time,\" says CEO Stephen Lebovitz.</li><li>Other players of note this morning: Washington Prime (<a href='https://seekingalpha.com/symbol/WPG' title='Washington Prime Group Inc.'>WPG</a> <font color=\"red\">-8%</font>), Taubman Centers (<a href='https://seekingalpha.com/symbol/TCO' title='Taubman Centers, Inc.'>TCO</a> <font color=\"red\">-3.5%</font>), PREIT (<a href='https://seekingalpha.com/symbol/PEI' title='Pennsylvania Real Estate Investment Trust'>PEI</a> <font color=\"red\">-7.4%</font>), Kimco (<a href='https://seekingalpha.com/symbol/KIM' title='Kimco Realty Corporation'>KIM</a> flat), Federal Realty (<a href='https://seekingalpha.com/symbol/FRT' title='Federal Realty Investment Trust'>FRT</a> <font color=\"red\">-0.2%</font>), Whitestone REIT (<a href='https://seekingalpha.com/symbol/WSR' title='Whitestone REIT'>WSR</a> <font color=\"red\">-0.4%</font>), Tanger Factory (<a href='https://seekingalpha.com/symbol/SKT' title='Tanger Factory Outlet Centers, Inc.'>SKT</a> <font color=\"red\">-2.2%</font>), Macerich (<a href='https://seekingalpha.com/symbol/MAC' title='Macerich Company'>MAC</a> <font color=\"red\">-1.5%</font>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3523341\" data-linked=\"Retail landlords mull CBL&#39;s dividend suspension\" data-tweet=\"$CBL $WPG $TCO - Retail landlords mull CBL&#39;s dividend suspension https://seekingalpha.com/news/3523341-retail-landlords-mull-cbls-dividend-suspension?source=tweet\" data-url=\"https://seekingalpha.com/news/3523341-retail-landlords-mull-cbls-dividend-suspension\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>124&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523339\" data-ts=\"1575384826\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COUP\" target=\"_blank\">COUP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523339-coupa-targets-raised-after-beat-and-raise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Coupa targets raised after beat-and-raise</a></h4><ul><li>Needham (Buy) raises its Coupa Software (NASDAQ:<a href='https://seekingalpha.com/symbol/COUP' title='Coupa Software Incorporated'>COUP</a>) target from $160 to $171 after yesterday's <a href=\"https://seekingalpha.com/news/3523130-coupa-softwareminus-1_2-despite-beat-and-raise\" target=\"_blank\">beat-and-raise</a>.</li><li>The firm says that while \"investors may begin to question the scale of the beat, it remains clear that the fundamentals of the business remain strong.\"</li><li>Raymond James (Outperform) lifts the target by $20 to $170, saying \"we sense that investors may have expected a bit more upside.\" The firm praises the billings beat but sees \"healthy upside expectations\" are baked into the stock.</li><li>COUP shares are <font color=\"red\">down 6.7%</font> to $139.02.</li><li>The company has a Bullish average <a href=\"https://seekingalpha.com/symbol/COUP?s=coup\" target=\"_blank\">Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523339\" data-linked=\"Coupa targets raised after beat-and-raise\" data-tweet=\"$COUP - Coupa targets raised after beat-and-raise https://seekingalpha.com/news/3523339-coupa-targets-raised-after-beat-and-raise?source=tweet\" data-url=\"https://seekingalpha.com/news/3523339-coupa-targets-raised-after-beat-and-raise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523338\" data-ts=\"1575384764\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BBIO\" target=\"_blank\">BBIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523338-bridgebio-initiates-rolling-submission-of-u-s-application-for-bbpminus-870-in-mocd-type\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BridgeBio initiates rolling submission of U.S. application for BBP-870 in MoCD Type A</a></h4><ul><li>BridgeBio (<a href='https://seekingalpha.com/symbol/BBIO' title='BridgeBio Pharma, Inc.'>BBIO</a> <font color=\"green\">+1.4%</font>) launches its <a href=\"https://seekingalpha.com/pr/17716006-bridgebio-pharma-s-origin-biosciences-initiates-rolling-submission-of-new-drug-application-u\" target=\"_blank\">rolling NDA filing</a> with the FDA seeking approval to use fosdenopterin (BBP-870/ORGN001) to treat patients with an ultra-rare inherited metabolic disorder called <a href=\"https://ghr.nlm.nih.gov/condition/molybdenum-cofactor-deficiency\" target=\"_blank\">molybdenum cofactor deficiency type A</a> (MoCD Type A), characterized by irreversible brain damage in newborns.</li><li>Fosdenopterin is a cyclic pyranopterin monophosphate (cPMP) substrate replacement therapy designed to reduce the buildup of toxic sulfites thereby alleviating central nervous system symptoms in MoCD Type A sufferers. It has Orphan Drug, Rare Pediatric Disease Designation and Breakthrough Therapy status in the U.S. for the indication.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523338\" data-linked=\"BridgeBio initiates rolling submission of U.S. application for BBP-870 in MoCD Type A\" data-tweet=\"$BBIO - BridgeBio initiates rolling submission of U.S. application for BBP-870 in MoCD Type A https://seekingalpha.com/news/3523338-bridgebio-initiates-rolling-submission-of-u-s-application-for-bbpminus-870-in-mocd-type?source=tweet\" data-url=\"https://seekingalpha.com/news/3523338-bridgebio-initiates-rolling-submission-of-u-s-application-for-bbpminus-870-in-mocd-type\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:52 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523335\" data-ts=\"1575384233\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IGT\" target=\"_blank\">IGT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523335-international-game-technology-announces-resignation-of-cfo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">International Game Technology announces resignation of its CFO</a></h4><ul><li>International Game Technology (<a href='https://seekingalpha.com/symbol/IGT' title='International Game Technology PLC'>IGT</a> <font color=\"red\">-3.2%</font>) <a href=\"https://seekingalpha.com/pr/17715504-international-game-technology-plc-announces-departure-of-chief-financial-officer-alberto\" target=\"_blank\">announced</a> that Alberto Fornaro, EVP &amp; CFO has resigned, however he will continue in his current position through January 31, 2020.</li><li>Timothy Rishton, current IGT's SVP and Chief Accounting Officer, has been appointed as interim CFO; he has been with the company for the past 24 years and has served in various positions.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523335\" data-linked=\"International Game Technology announces resignation of its CFO\" data-tweet=\"$IGT - International Game Technology announces resignation of its CFO https://seekingalpha.com/news/3523335-international-game-technology-announces-resignation-of-cfo?source=tweet\" data-url=\"https://seekingalpha.com/news/3523335-international-game-technology-announces-resignation-of-cfo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:43 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523329\" data-ts=\"1575383304\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CCC\" target=\"_blank\">CCC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523329-clarivate-analytics-announces-secondary-offering-of-shares-certain-selling-shareholders\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Clarivate Analytics announces secondary offering of shares by certain selling shareholders</a></h4><ul><li>Clarivate Analytics (NYSE:<a href='https://seekingalpha.com/symbol/CCC' title='Clarivate Analytics Plc'>CCC</a>) drops <font color=\"red\">4.85%</font> in pre-market as the company <a href=\"https://seekingalpha.com/pr/17715516-clarivate-analytics-plc-announces-secondary-offering-of-ordinary-shares\" target=\"_blank\">announced</a> that Onex Corporation and Baring Private Equity Asia Group, together with certain other shareholders, intend to offer 36M shares in an underwritten public offering.</li><li>The selling shareholders have granted the underwriters an option to purchase up to 5.4M additional shares.</li><li>The Company will not receive any of the proceeds from the offering</li></ul><div class=\"tiny-share-widget\" data-id=\"3523329\" data-linked=\"Clarivate Analytics announces secondary offering of shares by certain selling shareholders\" data-tweet=\"$CCC - Clarivate Analytics announces secondary offering of shares by certain selling shareholders https://seekingalpha.com/news/3523329-clarivate-analytics-announces-secondary-offering-of-shares-certain-selling-shareholders?source=tweet\" data-url=\"https://seekingalpha.com/news/3523329-clarivate-analytics-announces-secondary-offering-of-shares-certain-selling-shareholders\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:28 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523328\" data-ts=\"1575383273\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523328-healthcare-dominates-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare dominates premarket gainers</a></h4><ul><li>Audentes Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/BOLD' title='Audentes Therapeutics, Inc.'>BOLD</a>) <font color=\"green\">+105%</font> as Astellas Pharma to <a href=\"https://seekingalpha.com/news/3523217-astellas-pharma-to-buy-audentes-therapeutics-for-60-share\" target=\"_blank\">buy</a> Audentes Therapeutics for $60/share.</li><li>ViewRay (NASDAQ:<a href='https://seekingalpha.com/symbol/VRAY' title='ViewRay, Inc.'>VRAY</a>) <font color=\"green\">+36%</font> on <a href=\"https://seekingalpha.com/news/3523164-viewray-up-37-after-hours-on-elekta-collaboration\" target=\"_blank\">Elekta collaboration</a>.</li><li>uniQure N.V. (NASDAQ:<a href='https://seekingalpha.com/symbol/QURE' title='uniQure N.V.'>QURE</a>) <font color=\"green\">+16%</font>.</li><li>Axsome Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/AXSM' title='Axsome Therapeutics, Inc.'>AXSM</a>) <font color=\"green\">+10%</font> as <a href=\"https://seekingalpha.com/news/3523255-axsomes-axsminus-12-achieves-primary-endpoint-in-mid-stage-narcolepsy-study-shares-up-6\" target=\"_blank\">AXS-12 achieves primary endpoint</a> in mid-stage narcolepsy study.</li><li>Abeona Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ABEO' title='Abeona Therapeutics Inc.'>ABEO</a>) <font color=\"green\">+9%</font> as <a href=\"https://seekingalpha.com/news/3523311-gene-therapy-stocks-in-focus-after-astellas-audentes-deal\" target=\"_blank\">Gene therapy stocks</a> in focus after Astellas/Audentes deal.</li><li>REGENXBIO (NASDAQ:<a href='https://seekingalpha.com/symbol/RGNX' title='REGENXBIO Inc.'>RGNX</a>) <font color=\"green\">+8%</font>.</li><li>Sangamo Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SGMO' title='Sangamo Therapeutics, Inc.'>SGMO</a>) <font color=\"green\">+7%</font> as <a href=\"https://seekingalpha.com/news/3523311-gene-therapy-stocks-in-focus-after-astellas-audentes-deal\" target=\"_blank\">Gene therapy stocks</a> in focus after Astellas/Audentes deal.</li><li>Lands' End, Inc. (NASDAQ:<a href='https://seekingalpha.com/symbol/LE' title='Lands&#39; End, Inc.'>LE</a>) <font color=\"green\">+7%</font> after <a href=\"https://seekingalpha.com/news/3523258-lands-end-eps-beats-0_03-misses-on-revenue\" target=\"_blank\">Q3 results</a>.</li><li>Voyager Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/VYGR' title='Voyager Therapeutics, Inc.'>VYGR</a>) <font color=\"green\">+6%</font> as <a href=\"https://seekingalpha.com/news/3523311-gene-therapy-stocks-in-focus-after-astellas-audentes-deal\" target=\"_blank\">Gene therapy stocks</a> in focus after Astellas/Audentes deal.</li><li>AK Steel Holding (NYSE:<a href='https://seekingalpha.com/symbol/AKS' title='AK Steel Holding Corporation'>AKS</a>) <font color=\"green\">+6%</font> as Cleveland-Cliffs <a href=\"https://seekingalpha.com/news/3523270-cleveland-cliffs-buys-ak-steel-in-1_1b-stock-deal\" target=\"_blank\">buys AK Steel</a> in $1.1B stock deal.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523328\" data-linked=\"Healthcare dominates premarket gainers\" data-tweet=\"$BOLD $VRAY $QURE - Healthcare dominates premarket gainers https://seekingalpha.com/news/3523328-healthcare-dominates-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3523328-healthcare-dominates-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:27 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523327\" data-ts=\"1575383257\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523327-cbl-clf-among-premarket-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CBL, CLF among premarket losers</a></h4><ul><li>ASLAN Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ASLN' title='ASLAN Pharmaceuticals Limited'>ASLN</a>) <font color=\"red\">-50%</font> on <a href=\"https://seekingalpha.com/news/3523253-aslan-pharma-down-45-premarket-on-pricing-equity-offering\" target=\"_blank\">pricing</a> equity offering.</li><li>CBL &amp; Associates Properties (NYSE:<a href='https://seekingalpha.com/symbol/CBL' title='CBL & Associates Properties, Inc'>CBL</a>) <font color=\"red\">-36%</font> after <a href=\"https://seekingalpha.com/news/3523216-cbl-suspends-all-dividends-expects-drop-in-2020-income\" target=\"_blank\">suspending all future dividends</a> on its common and preferred stock.</li><li>Aldeyra Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ALDX' title='Aldeyra Therapeutics, Inc.'>ALDX</a>) <font color=\"red\">-30%</font> on <a href=\"https://seekingalpha.com/news/3523322-aldeyra-down-27-premarket-on-mixed-results-from-late-stage-reproxalap-study\" target=\"_blank\">mixed results</a> from late-stage reproxalap study.</li><li>Cara Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/CARA' title='Cara Therapeutics, Inc.'>CARA</a>) <font color=\"red\">-22%</font> after announcing results from its <a href=\"https://seekingalpha.com/news/3523276-cara-therapeutics-down-19-premarket-on-mixed-results-from-korsuva-study\" target=\"_blank\">Phase 2 trial of oral Korsuva</a>.</li><li>Cleveland-Cliffs (NYSE:<a href='https://seekingalpha.com/symbol/CLF' title='Cleveland-Cliffs Inc.'>CLF</a>) <font color=\"red\">-12%</font> after <a href=\"https://seekingalpha.com/news/3523270-cleveland-cliffs-buys-ak-steel-in-1_1b-stock-deal\" target=\"_blank\">acquisition</a> of AK Steel.</li><li>Coupa Software (NASDAQ:<a href='https://seekingalpha.com/symbol/COUP' title='Coupa Software Incorporated'>COUP</a>) <font color=\"red\">-6%</font> on <a href=\"https://seekingalpha.com/news/3523090-coupa-software-eps-beats-0_14-beats-on-revenue\" target=\"_blank\">Q3 earnings</a>.</li><li>AerCap (NYSE:<a href='https://seekingalpha.com/symbol/AER' title='AerCap Holdings N.V.'>AER</a>) <font color=\"red\">-4%</font> on announcing 4M <a href=\"https://seekingalpha.com/news/3523219-aercapminus-1_6-holders-file-to-offer-up-to-4m-shares\" target=\"_blank\">secondary offering</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3523327\" data-linked=\"CBL, CLF among premarket losers\" data-tweet=\"$ASLN $CBL $ALDX - CBL, CLF among premarket losers https://seekingalpha.com/news/3523327-cbl-clf-among-premarket-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3523327-cbl-clf-among-premarket-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:27 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523326\" data-ts=\"1575383092\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BYND\" target=\"_blank\">BYND</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523326-oppenheimer-cautious-on-beyond-meat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oppenheimer cautious on Beyond Meat</a></h4><ul> <li>Oppenheimer starts off coverage on Beyond Meat (NASDAQ:<a href='https://seekingalpha.com/symbol/BYND' title='Beyond Meat, Inc.'>BYND</a>) with a Market Perform rating.</li> <li>\"We overall look quite favorably upon the Beyond Meat brand, product assortment, track record of innovation, longer-term prospects, and positioning to the very on-trend alternative meat category. However, a pricey valuation, increasing competition, and the potential for new selling pressures following the expiration of the lock-up suggest more muted upside potential, in our view,\" sums up Oppenheimer analyst Rupesh Parikh.</li> <li>Parikh and team note that BYND currently trades at ~7X the FY21 sales forecast and ~57X the FY21 EBITDA forecast, a level that represents a premium to other consumer growth stories.</li> <li>Shares of BYND are <font color=\"red\">down 2.05%</font> premarket to $77.68.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3523326\" data-linked=\"Oppenheimer cautious on Beyond Meat\" data-tweet=\"$BYND - Oppenheimer cautious on Beyond Meat https://seekingalpha.com/news/3523326-oppenheimer-cautious-on-beyond-meat?source=tweet\" data-url=\"https://seekingalpha.com/news/3523326-oppenheimer-cautious-on-beyond-meat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>42&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3523325\" data-ts=\"1575383075\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VALE\" target=\"_blank\">VALE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3523325-iron-ore-futures-rise-vale-cuts-short-term-production-view\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Iron ore futures rise as Vale cuts short-term production view</a></h4><ul><li><a href=\"https://www.nasdaq.com/articles/china-iron-ore-futures-rebound-as-vale-lowers-q1-production-outlook-2019-12-03\" target=\"_blank\">China's iron ore futures rebounded</a> overnight after top iron ore miner Vale (NYSE:<a href='https://seekingalpha.com/symbol/VALE' title='Vale S.A.'>VALE</a>) lowered its Q1 2020 production outlook to 68M-73M metric tons from prior guidance 70M-75M mt.</li><li>The most-traded iron ore contract on the Dalian Commodity Exchange, expiring next month, settled 1.7% higher at 651.50 yuan/mt ($92.56) after rising as much as 2.2% during the session.</li><li><a href=\"https://seekingalpha.com/news/3523059-vale-updates-estimates-investor-day\" target=\"_blank\">Vale said yesterday</a> it planned to cut production at its Brucutu mine in Brazil for as long as two months as it evaluates the stability of the nearby Laranjeiras dam, leaving the mine operating at just 40% of normal capacity.</li><li>The revised outlook comes as iron ore inventory at ports in China has dropped to the lowest in nearly 10 weeks while steel demand remains firm.</li><li>Global producers are indicated sharply lower, however, on sudden pessimism over the likelihood of a U.S.-China trade deal: <a href='https://seekingalpha.com/symbol/BHP' title='BHP Group'>BHP</a> <font color=\"red\">-2.7%</font>, <a href='https://seekingalpha.com/symbol/RIO' title='Rio Tinto Group'>RIO</a> <font color=\"red\">-1.6%</font>.</li><li>Other relevant tickers include <a href='https://seekingalpha.com/symbol/FSUMF' title='Fortescue Metals Group Limited'>OTCQX:FSUMF</a>, <a href='https://seekingalpha.com/symbol/AAUKF' title='Anglo American plc'>OTCQX:AAUKF</a>, <a href='https://seekingalpha.com/symbol/AAUKY' title='Anglo American plc ADR'>OTCPK:AAUKY</a>, <a href='https://seekingalpha.com/symbol/GLCNF' title='Glencore plc'>OTCPK:GLCNF</a>, <a href='https://seekingalpha.com/symbol/GLNCY' title='Glencore plc'>OTCPK:GLNCY</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3523325\" data-linked=\"Iron ore futures rise as Vale cuts short-term production view\" data-tweet=\"$VALE $BHP $RIO - Iron ore futures rise as Vale cuts short-term production view https://seekingalpha.com/news/3523325-iron-ore-futures-rise-vale-cuts-short-term-production-view?source=tweet\" data-url=\"https://seekingalpha.com/news/3523325-iron-ore-futures-rise-vale-cuts-short-term-production-view\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}